Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
(Mark One)
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  For the quarterly period ended June 30, 2017
or
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                  to                 
 
Commission File Number: 000-15760
HARDINGEHORIZ646A04A12.JPG  
Hardinge Inc.
(Exact name of registrant as specified in its charter)  
New York
 
16-0470200
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
One Hardinge Drive
Elmira, NY
 
14902
(Address of principal executive offices)
 
(Zip Code)
(607) 734-2281
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                      ý Yes  o No
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).                      ý Yes  o No
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer o
 
Accelerated filer  x
Non-accelerated filer o   (Do not check if a smaller reporting company)
 
Smaller reporting company  o
 
 
Emerging growth company  o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      o Yes   ý No

 As of July 31, 2017 there were 12,949,525 shares of Common Stock of the registrant outstanding.
 

1

Table of Contents


HARDINGE INC. AND SUBSIDIARIES
TABLE OF CONTENTS
 
 
 
 
PAGE
 
 
 
 
 
 
Consolidated Balance Sheets at June 30, 2017 and December 31, 2016 (Audited)
 
 
Consolidated Statements of Operations for the three and six months ended June 30, 2017 and 2016
 
 
Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 30, 2017 and 2016
 
 
Consolidated Statements of Cash Flows for the six months ended June 30, 2017 and 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Certifications
 
 
 
 
 
 


2

Table of Contents

PART I — FINANCIAL INFORMATION
 
Item 1. Financial Statements.


HARDINGE INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
 
June 30,
2017
 
December 31,
2016
 
(Unaudited)
 
 
Assets
 

 
 

Cash and cash equivalents
$
26,369

 
$
28,255

Restricted cash
2,509

 
2,923

Accounts receivable, net
55,071

 
55,573

Inventories, net
118,478

 
107,018

Other current assets
11,321

 
6,926

Total current assets
213,748

 
200,695

 
 
 
 
Property, plant and equipment, net
57,192

 
56,961

Goodwill
6,658

 
6,579

Other intangible assets, net
26,698

 
26,730

Other non-current assets
6,047

 
6,585

Total non-current assets
96,595

 
96,855

Total assets
$
310,343

 
$
297,550

 
 
 
 
Liabilities and shareholders’ equity
 

 
 

Notes payable to bank
$
99

 
$
703

Accounts payable
25,982

 
24,217

Accrued expenses
27,140

 
25,629

Customer deposits
23,063

 
18,215

Accrued income taxes
671

 
1,160

Current portion of long-term debt
4,636

 
2,923

Total current liabilities
81,591

 
72,847

 
 
 
 
Long-term debt

 
2,970

Pension and postretirement liabilities
57,635

 
58,840

Deferred income taxes
4,343

 
3,800

Other liabilities
1,669

 
3,152

Total non-current liabilities
63,647

 
68,762

Commitments and contingencies (see Note 10)


 


Common stock ($0.01 par value, 20,000,000 authorized; shares issued 12,943,789 and 12,903,037)
129

 
129

Additional paid-in capital
121,489

 
121,015

Retained earnings
89,510

 
89,557

Treasury shares (at cost, 0 and 9,243)

 
(104
)
Accumulated other comprehensive loss
(46,023
)
 
(54,656
)
Total shareholders’ equity
165,105

 
155,941

Total liabilities and shareholders’ equity
$
310,343

 
$
297,550

 
See accompanying notes to the unaudited consolidated financial statements.


3

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2017
 
2016
 
2017
 
2016
 
(Unaudited)
 
(Unaudited)
Sales
$
78,197

 
$
70,186

 
$
142,754

 
$
138,007

Cost of sales
51,568

 
46,633

 
94,738

 
91,711

Gross profit
26,629

 
23,553

 
48,016

 
46,296

 
 
 
 
 
 
 
 
Selling, general and administrative expenses
20,081

 
19,637

 
38,103

 
40,230

Research & development
3,777

 
3,369

 
7,335

 
6,656

Restructuring
542

 
226

 
1,978

 
426

Other expense (income), net
37

 
20

 
192

 
(72
)
Income (loss) from operations
2,192

 
301

 
408

 
(944
)
 
 
 
 
 
 
 
 
Interest expense
104

 
132

 
210

 
285

Interest income
(38
)
 
(69
)
 
(79
)
 
(136
)
Income (loss) before income taxes
2,126

 
238

 
277

 
(1,093
)
Income tax (benefit) expense
(396
)
 
93

 
(198
)
 
8

Net Income (loss)
$
2,522

 
$
145

 
$
475

 
$
(1,101
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per share data:
 

 
 

 
 

 
 

Basic earnings (loss) per share:
$
0.20

 
$
0.01

 
$
0.04

 
$
(0.09
)
 
 
 
 
 
 
 
 
Diluted earnings (loss) per share:
$
0.20

 
$
0.01

 
$
0.04

 
$
(0.09
)
 
 
 
 
 
 
 
 
Cash dividends declared per share:
$
0.02

 
$
0.02

 
$
0.04

 
$
0.04

 
See accompanying notes to the unaudited consolidated financial statements.


4

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)
 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2017
 
2016
 
2017
 
2016
 
(Unaudited)
 
(Unaudited)
Net income (loss)
$
2,522

 
$
145

 
$
475

 
$
(1,101
)
Other comprehensive income (loss):
 

 
 

 
 

 
 

Foreign currency translation adjustments
4,675

 
(2,840
)
 
8,933

 
899

Retirement plans related adjustments
(527
)
 
1,575

 
(251
)
 
1,302

Unrealized (loss) gain on cash flow hedges
(299
)
 
(33
)
 
(68
)
 
132

Other comprehensive income (loss) before tax
3,849

 
(1,298
)
 
8,614

 
2,333

Income tax (benefit) expense
(438
)
 
282

 
(19
)
 
105

Other comprehensive income (loss), net of tax
4,287

 
(1,580
)
 
8,633

 
2,228

Total comprehensive income (loss)
$
6,809

 
$
(1,435
)
 
$
9,108

 
$
1,127

 
See accompanying notes to the unaudited consolidated financial statements.


5

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
Six Months Ended 
 June 30,
 
2017
 
2016
 
(Unaudited)
Operating activities
 

 
 

Net income (loss)
$
475

 
$
(1,101
)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
 

 
 

Impairment
1,401

 

Depreciation and amortization
4,411

 
4,098

Debt issuance costs amortization
65

 
66

Deferred income taxes
132

 
(119
)
Gain on sale of assets
(16
)
 
(4
)
Unrealized foreign currency transaction gain
(819
)
 
(116
)
Changes in operating assets and liabilities:
 

 
 

Accounts receivable
2,261

 
11,826

Restricted cash
499

 
(331
)
Inventories
(8,251
)
 
(7,720
)
Other assets
(2,893
)
 
(1,330
)
Accounts payable
745

 
(2,170
)
Customer deposits
4,132

 
(3,886
)
Accrued expenses
(2,381
)
 
(5,211
)
Accrued pension and postretirement liabilities
(19
)
 
(41
)
Net cash used in operating activities
(258
)
 
(6,039
)
 
 
 
 
Investing activities
 

 
 

Capital expenditures
(968
)
 
(992
)
Proceeds from sales of assets
16

 
37

Net cash used in investing activities
(952
)
 
(955
)
 
 
 
 
Financing activities
 

 
 

Proceeds from short-term notes payable to bank
12,418

 
28,871

Repayments of short-term notes payable to bank
(13,062
)
 
(28,643
)
Repayments of long-term debt
(1,456
)
 
(2,271
)
Dividends paid
(516
)
 
(536
)
Net cash used in financing activities
(2,616
)
 
(2,579
)
 
 
 
 
Effect of exchange rate changes on cash
1,940

 
167

Net decrease in cash
(1,886
)
 
(9,406
)
 
 
 
 
Cash and cash equivalents at beginning of period
28,255

 
32,774

 
 
 
 
Cash and cash equivalents at end of period
$
26,369

 
$
23,368


See accompanying notes to the unaudited consolidated financial statements.

6


HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2017



NOTE 1.  BASIS OF PRESENTATION
 
In these notes, the terms “Hardinge,” “the Company,” "we," "us," "our," or similar references mean Hardinge Inc. and its predecessors together with its subsidiaries.
 
The Company operates through two reportable segments, Metalcutting Machine Solutions (“MMS”) and Aftermarket Tooling and Accessories (“ATA”). The MMS segment includes high precision computer controlled metalcutting turning machines, vertical machining centers, horizontal machining centers, grinding machines, and repair parts related to those machines. The ATA segment includes products, primarily collets and chucks that are purchased by manufacturers throughout the lives of their Hardinge or other branded machines.
 
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements and, therefore, should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 . The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the timing and amount of assets, liabilities, equity, revenue, and expenses reported and disclosed. Actual amounts could differ from these estimates. All adjustments, consisting of normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the results for the interim periods have been presented and recorded. Due to differing business conditions and some seasonality, operating results for the three and six months ended June 30, 2017 are not necessarily indicative of the results that may be expected in subsequent quarters or for the full year ended December 31, 2017 .

Certain amounts in the June 30, 2016 consolidated financial statements have been reclassified to conform to the current presentation.

NOTE 2.  FAIR VALUE OF FINANCIAL INSTRUMENTS
 
The inputs to the valuation techniques used to measure fair value are classified into the following categories:
 
Level 1 — Quoted prices in active markets for identical assets and liabilities.
 
Level 2 — Observable inputs other than quoted prices in active markets for similar assets and liabilities.
 
Level 3 — Inputs for which significant valuation assumptions are unobservable in a market and therefore value is based on the best available data, some of which is internally developed and considers risk premiums that a market participant would require.


7

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

The following table presents the carrying amount, fair values, and classification level within the fair value hierarchy of financial instruments measured or disclosed at fair value on a recurring basis (in thousands):
 
June 30, 2017
 
December 31, 2016
 
Level of Fair Value Hierarchy
 
Carrying Amount
 
Fair Value
 
Carrying Amount
 
Fair Value
 
Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
26,369

 
$
26,369

 
$
28,255

 
$
28,255

 
Level 1
Restricted cash
2,509

 
2,509

 
2,923

 
2,923

 
Level 1
Foreign currency forward contracts
373

 
373

 
308

 
308

 
Level 2
Liabilities:
 
 
 
 
 
 
 
 
 
Notes payable to bank
99

 
99

 
703

 
703

 
Level 2
Variable interest rate debt
4,696

 
4,696

 
5,986

 
5,986

 
Level 2
Foreign currency forward contracts
725

 
725

 
566

 
566

 
Level 2
 
The fair value of cash and cash equivalents and restricted cash are based on the fair values of identical assets in active markets. Due to the short period to maturity or the nature of the underlying liability, the fair value of notes payable to bank and variable interest rate debt approximates their respective carrying amounts. The fair value of foreign currency forward contracts is measured using models based on observable market inputs such as spot and forward rates. Based on the Company’s continued ability to enter into forward contracts, the markets for the fair value instruments are considered to be active. As of June 30, 2017 and December 31, 2016 , there were no significant transfers in and/or out of Level 1 and Level 2.
 
NOTE 3.  INVENTORIES
 
Net inventories are stated at the lower of cost (computed in accordance with the first-in, first-out method) or net realizable value. Elements of the cost include materials, labor and overhead.
 
Net inventories consist of the following (in thousands):
 
June 30,
2017
 
December 31,
2016
Raw materials and purchased components
$
32,867

 
$
33,822

Work-in-process
37,624

 
31,799

Finished products
47,987

 
41,397

Inventories, net
$
118,478

 
$
107,018


NOTE 4.  DERIVATIVE FINANCIAL INSTRUMENTS
 
Foreign currency forward contracts are utilized to mitigate the impact of currency fluctuations on assets and liabilities denominated in foreign currencies as well as on forecasted transactions denominated in foreign currencies. These contracts are considered derivative instruments and are recognized as either assets or liabilities and measured at fair value. For contracts that are designated and qualify as cash flow hedges, the gain or loss on the contracts is reported as a component of other comprehensive income (“OCI”) and reclassified from accumulated other comprehensive income (“AOCI”) into the “Sales” or “Cost of sales” line item on the Consolidated Statements of Operations when the underlying hedged transaction affects earnings, or “ Other expense (income), net ” when the hedging relationship is deemed to be ineffective. As of June 30, 2017 and December 31, 2016 , the notional amounts of the derivative financial instruments designated to qualify for cash flow hedges were $35.7 million and $45.5 million , respectively. The Company expects that approximately $0.1 million of expense, net of income tax effect, to be reclassified from AOCI to earnings within the next 12 months. 

As of June 30, 2017 and December 31, 2016 , the notional amounts of the derivative financial instruments not qualifying or otherwise designated as hedges were $26.3 million and $35.4 million , respectively. For the three months ended June 30, 2017 and 2016 , losses of $0.2 million and gains of $0.4 million , respectively, were recorded related to this type of derivative financial instrument. For the six months ended June 30, 2017 and 2016 , gains of $0.4 million and losses of $0.02 million ,

8

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

respectively, were recorded related to this type of derivative financial instrument. For contracts that are not designated as hedges, the gain or loss on the contract is recognized in current earnings in the “ Other expense (income), net ” line item on the Consolidated Statements of Operations .
 
The following table presents the fair value on the Consolidated Balance Sheets of the foreign currency forward contracts (in thousands):
 
June 30,
2017
 
December 31,
2016
Foreign currency forwards designated as hedges:
 

 
 

Other current assets
$
196

 
$
153

Accrued expenses
(370
)
 
(264
)
Foreign currency forwards not designated as hedges:
 

 
 

Other current assets
177

 
155

Accrued expenses
(355
)
 
(302
)
Foreign currency forwards, net
$
(352
)
 
$
(258
)
 
NOTE 5.  PROPERTY, PLANT AND EQUIPMENT
 
Property, plant and equipment consists of the following (in thousands): 
 
June 30,
2017
 
December 31,
2016
Land, buildings and improvements
$
84,651

 
$
81,311

Machinery, equipment and fixtures
77,541

 
75,177

Office furniture, equipment and vehicles
23,204

 
22,471

Construction in progress
212

 
272

 
185,608

 
179,231

Accumulated depreciation
(128,416
)
 
(122,270
)
Property, plant and equipment, net
$
57,192

 
$
56,961


NOTE 6.  GOODWILL AND INTANGIBLE ASSETS
 
Detail and activity of goodwill by segment is presented below (in thousands):
 
MMS
 
ATA
 
Total
Goodwill
$
32,434

 
$
6,579

 
$
39,013

Accumulated impairment losses
(32,434
)
 

 
(32,434
)
Balance at December 31, 2016

 
6,579

 
6,579

 
 
 
 
 
 
Goodwill
32,434

 
6,579

 
39,013

Currency translation adjustments

 
79

 
79

Accumulated impairment losses
(32,434
)
 

 
(32,434
)
Balance at June 30, 2017
$

 
$
6,658

 
$
6,658


    

9

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

The major components of intangible assets other than goodwill are as follows (in thousands):
 
June 30,
2017
 
December 31,
2016
Gross amortizable intangible assets:
 

 
 

Technical know-how
$
12,985

 
$
12,944

Customer lists
9,016

 
8,981

Land rights
2,559

 
2,498

Patents, trade names, drawings, and other
4,391

 
4,356

Total gross amortizable intangible assets
28,951

 
28,779

 
 
 
 
Accumulated amortization:
 

 
 

Technical know-how
(7,758
)
 
(7,438
)
Customer lists
(1,976
)
 
(1,744
)
Land rights
(337
)
 
(304
)
Patents, trade names, drawings, and other
(3,587
)
 
(3,490
)
Total accumulated amortization
(13,658
)
 
(12,976
)
Amortizable intangible assets, net
15,293

 
15,803

 
 
 
 
Indefinite lived intangible assets:
 

 
 

Trade names
11,405

 
10,927

 
 
 
 
Intangible assets other than goodwill, net
$
26,698

 
$
26,730


Amortization expense related to the definite-lived intangible assets are as follows (in thousands):
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2017
 
2016
 
2017
 
2016
Amortization expense
$
312

 
$
320

 
$
624

 
$
640


NOTE 7.  WARRANTIES
 
A reconciliation of the changes in the product warranty accrual, which is included in " Accrued expenses " in the Consolidated Balance Sheets, is as follows (in thousands):
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2017
 
2016
 
2017
 
2016
Balance at the beginning of period
$
3,266

 
$
3,521

 
$
3,556

 
$
3,802

Warranties issued
473

 
709

 
845

 
1,081

Warranty settlement costs
(479
)
 
(557
)
 
(852
)
 
(1,147
)
Changes in accruals for pre-existing warranties
(36
)
 
62

 
(381
)
 
64

Currency translation adjustments
100

 
89

 
156

 
24

Balance at the end of period
$
3,324

 
$
3,824

 
$
3,324

 
$
3,824



10

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

NOTE 8.  RESTRUCTURING CHARGES
 
In March 2017, management initiated a strategic restructuring program (the "Program") in our MMS segment with the goals of streamlining the Company's cost structure, increasing operational efficiencies, generating cash and improving shareholder returns. This Program consists of rationalizing certain product lines, consolidating certain European manufacturing operations, and the sale of assets. The Program, which is projected to be substantially complete by mid-2018, is expected to generate annual pre-tax savings in the range of approximately $2.0 million to $2.5 million once fully implemented. Of the total costs estimated below, we expect approximately $1.6 million will be non-cash costs.

Restructuring charges are included in the "Restructuring" line item in the Consolidated Statements of Operations. The table below presents the total costs expected to be incurred in connection with the Program, the amount of costs that have been recognized during the three and six months ended June 30, 2017 and the cumulative costs recognized to date by the Program (in thousands):
 
Total Costs Expected to be Incurred
 
Cost Recognized for Three Months Ended June 30, 2017
 
Cost Recognized for Six Months Ended June 30, 2017 (Cumulative costs recognized to date)
Restructuring:
 
 
 
 
 
Employee termination costs
$
1,010

 
$
393

 
$
393

Inventory Impairment
1,401

 

 
1,401

Facility related costs
1,373

 
105

 
115

Other related costs
492

 
44

 
69

Total Restructuring Activity
$
4,276

 
$
542

 
$
1,978


The amounts accrued associated with the Program are included in "Accrued expenses" and "Inventory" in the Consolidated Balance Sheets. A rollforward of the accrued restructuring costs is presented below (in thousands):
Balance at December 31, 2016
$

Restructuring charges:
 
Employee termination costs
393

Inventory Impairment
1,401

Facility related costs
115

Other related costs
69

Total restructuring charges for the period
1,978

 
 
Cash expenditures
(373
)
Other adjustments to accrual

Foreign currency translation adjustment
80

Balance at June 30, 2017
$
1,685


NOTE 9.  INCOME TAXES
 
A valuation allowance is recorded against all or a portion of the deferred tax assets in the U.S., Canada, U.K., Germany, and the Netherlands.
 
Each quarter, a full year tax rate is estimated for jurisdictions not subject to valuation allowances based upon the most recent forecast of full year anticipated results and the year-to-date tax expense is adjusted to reflect the full year anticipated tax rate. The rate is an estimate based upon projected results for the year, estimated annual permanent differences, the statutory tax rates in the various jurisdictions in which the Company operates, and the non-recognition of tax benefits for entities with full valuation allowances. The overall effective tax rate was (18.6)% and (71.5)% for the three and six months ended June 30, 2017 . The tax benefit recorded during the three months ended June 30, 2017 is mainly driven by the release of an uncertain tax position due to the lapsing of the statute of limitations resulting in a tax benefit of $0.6 million .


11

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017


The tax years 2013 through 2016 remain open to examination by the U.S. federal taxing authorities. The tax years 2011 through 2016 remain open to examination by the U.S. state taxing authorities. For other major jurisdictions (Switzerland, U.K., Taiwan, France, Germany, Netherlands, China and India), the tax years between 2009 and 2016 generally remain open to routine examination by foreign taxing authorities, depending on the jurisdiction.
 
At June 30, 2017 , a liability of $1.4 million is recorded with respect to uncertain income tax positions, which includes related interest of $0.1 million . If recognized, essentially all of the uncertain tax positions and related interest at June 30, 2017 would be recorded as a benefit to income tax expense on the Consolidated Statements of Operations . It is reasonably possible that some of the uncertain tax positions pertaining to foreign operations may change within the next 12 months due to audit settlements and statute of limitations expirations. The change in uncertain tax positions for these potential settlements is estimated to be up to $1.2 million .

NOTE 10.  COMMITMENTS AND CONTINGENCIES
 
The Company is a defendant in various lawsuits as a result of normal operations and in the ordinary course of business. Management believes the outcome of these lawsuits will not have a material effect on the financial position or results of operations.

The Company’s operations are subject to extensive federal, state, local and foreign laws and regulations relating to environmental matters. Certain environmental laws can impose joint and several liability for releases or threatened releases of hazardous substances upon certain statutorily defined parties regardless of fault or the lawfulness of the original activity or disposal. Hazardous substances and adverse environmental effects have been identified with respect to real property owned by the Company, and on adjacent parcels of real property.

In particular, the Elmira, NY manufacturing facility is located within the Kentucky Avenue Wellfield on the National Priorities List of hazardous waste sites designated for cleanup by the United States Environmental Protection Agency (“EPA”) because of groundwater contamination. The Kentucky Avenue Wellfield Site (the “Site”) encompasses an area which includes sections of the Town of Horseheads and the Village of Elmira Heights in Chemung County, NY. In February 2006, the Company received a Special Notice Concerning a Remedial Investigation/Feasibility Study (“RI/FS”) for the Koppers Pond (the “Pond”) portion of the Site. The EPA documented the release and threatened release of hazardous substances into the environment at the Site, including releases into and in the vicinity of the Pond. The hazardous substances, including metals and polychlorinated biphenyls, have been detected in sediments in the Pond.

Until receipt of this Special Notice in February 2006, the Company had never been named as a potentially responsible party (“PRP”) at the Site nor had the Company received any requests for information from the EPA concerning the Site. Environmental sampling on the Company’s property within this Site under supervision of regulatory authorities had identified off-site sources for such groundwater contamination and sediment contamination in the Pond, and found no evidence that the Company’s operations or property have contributed or are contributing to the contamination. All appropriate insurance carriers have been notified, and the Company is actively cooperating with them, but whether coverage will be available has not yet been determined and possible insurance recovery cannot be estimated with any degree of certainty at this time.

A substantial portion of the Pond is located on the Company’s property. The Company, along with Beazer East, Inc., the Village of Horseheads, the Town of Horseheads, the County of Chemung, CBS Corporation and Toshiba America, Inc., (collectively, the "PRP's"), agreed to voluntarily participate in the RI/FS by signing an Administrative Settlement Agreement and Order of Consent on September 29, 2006. On September 29, 2006, the Director of Emergency and Remedial Response Division of the EPA, Region II, approved and executed the Agreement on behalf of the EPA. The PRP's also signed a PRP Member Agreement, agreeing to share the costs associated with the RI/FS study on a per capita basis. In June 2017, the EPA notified the PRP’s that two additional parties had been added to the group of PRP’s (Eaton Corporation and Elmira Water Board). The impact of these new parties to the cost sharing agreement has not yet been determined.

The EPA approved the RI/FS Work Plan in May of 2008. In July of 2012 the PRP's submitted a Remedial Investigation (RI) to respond to EPA issues raised in the initial draft RI. In January 2016, the PRP's submitted a draft Feasibility Study (FS), also to respond to issues raised by the EPA about previous drafts of the FS. In July 2016, the EPA announced its proposed

12

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

remediation plan based on an alternative put forth in a July 2016 Woodruff & Curran FS with an estimated total clean-up phase cost of $1.9 million . The preferred remedy consists of the placement of a continuous six-inch thick soil and sand cap, including a geotextile membrane to act as a demarcation layer, over Koppers Pond. The preferred remedy includes long-term monitoring and institutional controls. After a public comment period, on December 13, 2016, the EPA issued a Certificate of Completion confirming that the RI/FS was complete, confirming that all PRP obligations related to the RI/FS had been performed in accordance with the provisions of the Administrative Settlement Agreement and Order on Consent, and approving the remedy selected in the FS as the final response action for Koppers Pond.

The company has $0.3 million as of June 30, 2017 as a reserve for its estimated related liability, assuming all of the original PRP's would continue to share costs equally in the clean-up phase of the project. Based on our understanding including discussions with our experts, it is possible that the PRP's may change, the total clean-up liability may change, and/or the relative split of costs may be different for this final phase of the project. This reserve is reported in Accrued expenses in the Consolidated Balance Sheets.
    
Based upon information currently available, except as described in the preceding paragraphs, the Company does not have material liabilities for environmental remediation. Though the foregoing reflects the Company’s current assessment as it relates to environmental remediation obligations, it is possible that future remedial requirements or changes in the enforcement of existing laws and regulations, which are subject to extensive regulatory discretion, will result in material liabilities to the Company.

NOTE 11.  PENSION AND POSTRETIREMENT PLANS
 
A summary of the components of net periodic pension and postretirement benefit costs for the three and six months ended June 30, 2017 and 2016 is presented below (in thousands):
 
Pension Benefits
 
Postretirement Benefits
 
Three Months Ended 
 June 30,
 
Three Months Ended 
 June 30,
 
2017
 
2016
 
2017
 
2016
Service cost
$
487

 
$
569

 
$
3

 
$
3

Interest cost
1,504

 
1,676

 
18

 
19

Expected return on plan assets
(2,126
)
 
(2,328
)
 

 

Amortization of prior service credit
(78
)
 
(64
)
 

 

Amortization of transition asset

 
(79
)
 

 

Amortization of actuarial loss (gain)
935

 
957

 
(11
)
 
(14
)
Settlement loss (gain)
30

 

 

 

Net periodic cost
$
752


$
731


$
10


$
8

 
 
 
 
 
 
 
 
 
Pension Benefits
 
Postretirement Benefits
 
Six Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2017
 
2016
 
2017
 
2016
Service cost
$
974

 
$
1,128

 
$
6

 
$
6

Interest cost
3,002

 
3,348

 
36

 
38

Expected return on plan assets
(4,236
)
 
(4,637
)
 

 

Amortization of prior service credit
(154
)
 
(127
)
 

 

Amortization of transition asset

 
(156
)
 

 

Amortization of actuarial loss (gain)
1,867

 
1,900

 
(22
)
 
(28
)
Settlement loss (gain)
30

 

 

 

Net periodic cost
$
1,483

 
$
1,456

 
$
20

 
$
16



13

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

NOTE 12.  STOCK BASED COMPENSATION
 
The Company's 2011 Incentive Stock Plan (the "Plan"), as amended on May 6, 2014, permits the grant of several types of incentives, including share options, non-qualified stock options, stock appreciation rights, restricted stock awards/ units (“RSAs”) and performance share incentives (“PSIs”).

Stock Options

There were 225,000 non-qualified stock options granted in the three months ended June 30, 2017 . There were no other vested or unvested stock options outstanding at the time of these grants. The fair market value of stock options is estimated using the Black Scholes valuation model using the following assumptions:

 
Three Months ended June 30, 2017
Expected volatility
38.50%
Expected dividend yield
0.66%
Risk free rate
1.32% - 1.45%
Expected term (in years)
6.0 - 6.5
Weighted average grant date fair value
$4.48
Weighted average exercise price
$12.04

Stock options vest over a two or three -year period based on either a service period or a combination of service period and performance measures. Deferred compensation for stock options is amortized on a straight-line basis for stock options, which vest over a specified service period, and is recognized ratably for stock options which also have a performance requirement to the extent that it is probable that the performance target will be met. All stock options granted have a ten -year contractual term.

The intrinsic value of stock options at June 30, 2017 was $0.1 million , which is calculated as the difference between the stock price as of June 30, 2017 and the exercise price of the option.

Restricted Stock/ Unit Awards ("RSAs")

There were 42,350 RSAs granted during the six months ended June 30, 2017 , and no awards in the same period of 2016 . The deferred compensation for RSAs is amortized on a straight-line basis over the specified service period, which ranges from three to four years .

Performance Share Incentives ("PSIs")

There were 42,350 Performance Share Incentives ("PSIs") granted during the six months ended June 30, 2017 , and no awards in the same period of 2016 . The deferred compensation with respect to the PSIs is being recognized into earnings based on the passage of time and achievement of performance targets.     
    
Compensation Costs

Stock based compensation costs are based on estimated fair values. The fair value of service and performance based stock awards are based on the market value on the date of the grant. The fair value of stock options are estimated using a Black-Scholes valuation model. All stock based compensation to employees is recorded as " Selling, general and administrative expenses " in the Consolidated Statements of Operations . These non-cash compensation costs are included in the depreciation and amortization amounts in the Consolidated Statements of Cash Flows .
 

14

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

A summary of stock based compensation expense is as follows (in thousands):
 
Three Months Ended 
 June 30,
Six Months Ended 
 June 30,
 
2017
 
2016
2017
 
2016
Stock Options
$
31

 
$

$
31

 
$

Restricted stock/unit awards (“RSA”)
66

 
58

107

 
123

Performance share incentives (“PSI”)
32

 

39

 

Total stock based compensation
$
129

 
$
58

$
177

 
$
123

    
Unrecognized compensation and the expected weighted-average recognition periods with respect to the outstanding RSAs and PSIs as of June 30, 2017 and December 31, 2016 , are as follows:
 
June 30,
2017
 
December 31,
2016
 
Stock Options
 
RSAs
 
PSIs
 
Stock Options
 
RSAs
 
PSIs
Unrecognized compensation cost (in thousands)
$
976

 
$
464

 
$
904

 
$

 
$
113

 
$
520

Expected weighted-average recognition period for unrecognized compensation cost (in years)
2.67

 
1.65

 
1.51

 
N/A

 
0.92

 
0.97


NOTE 13.  CHANGES IN ACCUMULATED OTHER COMPREHENSIVE LOSS
 
Changes in AOCI by component for the three and six months ended June 30, 2017 and 2016 are as follows (in thousands):
 
Three Months ended June 30, 2017
 
Foreign
currency
translation
adjustments
 
Retirement
plans related
adjustments
 
Unrealized
gain (loss) on
cash flow
hedges
 
Accumulated
other
comprehensive
loss
Beginning balance, net of tax
$
19,324

 
$
(69,816
)
 
$
182

 
$
(50,310
)
Other comprehensive income (loss) before reclassifications
4,675

 
(1,403
)
 
(261
)
 
3,011

Less: (Loss) income reclassified from AOCI

 
(876
)
 
38

 
(838
)
Net other comprehensive income (loss)
4,675

 
(527
)
 
(299
)
 
3,849

Income taxes
(229
)
 
(155
)
 
(54
)
 
(438
)
Ending balance, net of tax
$
24,228

 
$
(70,188
)
 
$
(63
)
 
$
(46,023
)
 
Three Months Ended June 30, 2016
 
Foreign
currency
translation
adjustments
 
Retirement
plans related
adjustments
 
Unrealized
gain (loss) on
cash flow
hedges
 
Accumulated
other
comprehensive
loss
Beginning balance, net of tax
$
24,312

 
$
(69,221
)
 
$
4

 
$
(44,905
)
Other comprehensive (loss) income before
reclassifications
(2,840
)
 
775

 
(96
)
 
(2,161
)
Less: (loss) income reclassified from AOCI

 
(800
)
 
(63
)
 
(863
)
Net other comprehensive (loss) income
(2,840
)
 
1,575

 
(33
)
 
(1,298
)
Income taxes
113

 
169

 

 
282

Ending balance, net of tax
$
21,359

 
$
(67,815
)
 
$
(29
)
 
$
(46,485
)

15

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

 
Six Months Ended June 30, 2017
 
Foreign
currency
translation
adjustments
 
Retirement
plans related
adjustments
 
Unrealized
gain (loss) on
cash flow
hedges
 
Accumulated
other
comprehensive
loss
Beginning balance, net of tax
$
15,483

 
$
(70,102
)
 
$
(37
)
 
$
(54,656
)
Other comprehensive income (loss) before reclassifications
8,933

 
(1,972
)
 
(179
)
 
6,782

Less: (loss) income reclassified from AOCI

 
(1,721
)
 
(111
)
 
(1,832
)
Net other comprehensive income (loss)
8,933

 
(251
)
 
(68
)
 
8,614

Income taxes
188

 
(165
)
 
(42
)
 
(19
)
Ending balance, net of tax
$
24,228

 
$
(70,188
)
 
$
(63
)
 
$
(46,023
)

 
Six Months Ended June 30, 2016
 
Foreign
currency
translation
adjustments
 
Retirement
plans related
adjustments
 
Unrealized
gain (loss) on
cash flow
hedges
 
Accumulated
other
comprehensive
loss
Beginning balance, net of tax
$
20,529

 
$
(69,100
)
 
$
(142
)
 
$
(48,713
)
Other comprehensive income (loss) before reclassifications
899

 
(287
)
 
116

 
728

Less: (loss) income reclassified from AOCI

 
(1,589
)
 
(16
)
 
(1,605
)
Net other comprehensive income (loss)
899

 
1,302

 
132

 
2,333

Income taxes
69

 
17

 
19

 
105

Ending balance, net of tax
$
21,359

 
$
(67,815
)
 
$
(29
)
 
$
(46,485
)

16

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017


Details about reclassification out of AOCI for the three and six months ended June 30, 2017 and 2016 are as follows (in thousands):
 
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
Affected line item on the Consolidated Statements of Operations
Details of AOCI components
 
2017
 
2016
 
2017
 
2016
 
Unrealized gain (loss) on cash flow hedges: 
 
 

 
 

 
 
 
 
 
 
 
 
$
18

 
$
(53
)
 
$
(120
)
 
$
23

 
Sales
 
 
20

 
(10
)
 
9

 
(39
)
 
Other expense (income), net
 
 
38

 
(63
)
 
(111
)
 
(16
)
 
Total before tax
 
 
15

 
(10
)
 
(9
)
 
(3
)
 
Income taxes
 
 
$
53

 
$
(73
)
 
$
(120
)
 
$
(19
)
 
Net of tax
Retirement plans related adjustments:
 
 

 
 

 
 
 
 
 
 
Amortization of prior service credit
 
$
78

 
$
64

 
$
154

 
$
127

 
(a)
Amortization of transition asset
 

 
79

 

 
156

 
(a)
Amortization of actuarial loss
 
(924
)
 
(943
)
 
(1,845
)
 
(1,872
)
 
(a)
Settlement loss
 
(30
)
 

 
(30
)
 

 
(a)
 
 
(876
)

(800
)

(1,721
)

(1,589
)
 
Total before tax
 
 
96

 
85

 
184

 
168

 
Income taxes
 
 
$
(780
)
 
$
(715
)
 
$
(1,537
)
 
$
(1,421
)
 
Net of tax
 
(a)  These AOCI components are included in the computation of net periodic pension and post retirement costs. See Note 11. "Pension and Postretirement Plans" for details.
 
NOTE 14.  EARNINGS (LOSS) PER SHARE
 
Basic earnings per share is computed using the weighted average number of shares of common stock outstanding during the period. In periods of earnings, the weighted average number of shares used in the diluted calculation includes common stock equivalents related to stock options and restricted stock. The following table presents the basis of the earnings per share computation (in thousands):
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2017
 
2016
 
2017
 
2016
Numerator for basic and diluted loss per share:
 

 
 

 
 
 
 
Net earnings (loss) applicable to common shareholders
$
2,522

 
$
145

 
$
475

 
$
(1,101
)
 
 
 
 
 
 
 
 
Denominator for basic and diluted loss per share:
 

 
 

 
 
 
 
Denominator for basic and diluted loss per share — weighted average shares
12,894

 
12,812

 
12,887

 
12,804

Assumed exercise of stock options
1

 
22

 
1

 

Assumed satisfaction of restricted stock conditions
37

 
67

 
33

 

Denominator for diluted earnings per share — adjusted weighted average shares
12,932

 
12,901

 
12,921

 
12,804

 
Common stock equivalents of certain stock-based awards totaling 81,233 and 5,384 were excluded from the calculation of diluted earnings per share for the three months ended June 30, 2017 and June 30, 2016 , respectively, as they were anti-dilutive. Common stock equivalents of certain stock-based awards totaling 41,681 were excluded from the calculation of diluted earnings per share for the six months ended June 30, 2017 , as they were anti-dilutive. There is no dilutive effect of the

17

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

restricted stock and stock options for six months ended June 30, 2016 due to the net loss in this period. There would have been 94,666 of these shares included in the diluted calculation for the six months ended June 30, 2016 had there been earnings in this period.

NOTE 15. SEGMENT INFORMATION
 
Segment income (loss) is measured for internal reporting purposes by excluding corporate expenses, impairment charges, interest income, interest expense, and income taxes. Corporate expenses consist primarily of executive employment costs, certain professional fees, and costs associated with the Company’s global headquarters. Financial results for each reportable segment are as follows (in thousands):
 
Three Months ended June 30, 2017
 
MMS
 
ATA
 
Inter-Segment
Eliminations
 
Total
Sales
$
62,016

 
$
16,302

 
$
(121
)
 
$
78,197

Depreciation and amortization
1,429

 
495

 

 
1,924

Segment income
1,928

 
2,745

 


 
4,673

Capital expenditures
433

 
55

 

 
488

 
Three Months Ended June 30, 2016
 
MMS
 
ATA
 
Inter-Segment
Eliminations
 
Total
Sales
$
54,359

 
$
15,883

 
$
(56
)
 
$
70,186

Depreciation and amortization
1,494

 
526

 

 
2,020

Segment income
276

 
1,641

 


 
1,917

Capital expenditures
394

 
163

 

 
557

 
Six Months Ended June 30, 2017
 
MMS
 
ATA
 
Inter-Segment
Eliminations
 
Total
Sales
$
110,848

 
$
32,161

 
$
(255
)
 
$
142,754

Depreciation and amortization
2,829

 
1,003

 
0

 
3,832

Segment (loss) income
(741
)
 
5,031

 
 

 
4,290

Capital expenditures
768

 
200

 
 

 
968

Segment assets (1)
233,613

 
46,153

 
 

 
279,766

 
Six Months Ended June 30, 2016
 
MMS
 
ATA
 
Inter-Segment
Eliminations
 
Total
Sales
$
106,630

 
$
31,504

 
$
(127
)
 
$
138,007

Depreciation and amortization
2,921

 
1,064

 
 

 
3,985

Segment (loss) income
(880
)
 
3,495

 
 

 
2,615

Capital expenditures
685

 
307

 
 

 
992

Segment assets (1)
222,098

 
48,440

 
 

 
270,538

____________________
(1)  
Segment assets primarily consist of restricted cash, accounts receivable, inventories, prepaid and other assets, property, plant and equipment, and intangible assets. Unallocated assets primarily include, cash and cash equivalents, corporate property, plant and equipment, deferred income taxes, and other non-current assets.
 

18

Table of Contents

HARDINGE INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (continued)
JUNE 30, 2017

A reconciliation of segment income to consolidated income (loss) before income taxes for the three and six months ended June 30, 2017 and 2016 are as follows (in thousands):
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2017
 
2016
 
2017
 
2016
Segment income
$
4,673

 
$
1,917

 
$
4,290

 
$
2,615

Unallocated corporate expense
(2,481
)
 
(1,616
)
 
(3,882
)
 
(3,559
)
Interest expense, net
(66
)
 
(63
)
 
(131
)
 
(149
)
Income (loss) before income taxes
$
2,126

 
$
238

 
$
277

 
$
(1,093
)
 
A reconciliation of segment assets to consolidated total assets follows (in thousands):
 
June 30,
2017
 
December 31,
2016
Total segment assets
$
279,766

 
$
265,279

Unallocated assets
30,577

 
32,271

Total assets
$
310,343

 
$
297,550


Unallocated assets include cash of $26.4 million and $28.3 million at June 30, 2017 and December 31, 2016 , respectively.

NOTE 16.  NEW ACCOUNTING STANDARDS

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. establishing a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. This update provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services and will supersede most of the existing revenue recognition guidance, including industry-specific guidance. We have the option of using either a full retrospective or modified approach to adopt this guidance. Between August 2015 and May 2016, the FASB issued four additional updates to 1) ASU No. 2015-14, Deferral of the Effective Date , 2) ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), 3) ASU No. 2016-10, Identifying Performance Obligations and Licensing, and 4) ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients to provide further guidance and clarification in accounting for revenue arising from contracts with customers. The new guidance is effective for annual reporting periods beginning after December 15, 2017, and all annual and interim periods thereafter. In the first quarter 2017 the Company developed a project plan and timeline to complete a diagnostic assessment to begin developing solutions. This assessment has progressed in the second quarter of 2017 and has included an initial training of key personnel, sampling of contracts, and revenue stream evaluation. The Company has not determined the impact this standard may have on the financial statements, nor decided on the method of adoption. In the second half of 2017, the Company expects to implement and test any changes in policy, processes, systems and internal controls and compute required transition adjustments and disclosures.     
    

19


Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations.
 
Overview.   The following Management’s Discussion and Analysis (“MD&A”) contains information that the Company believes is necessary to attain an understanding of the Company’s financial condition and associated matters, including the Company’s liquidity, capital resources and results of operations. The MD&A is provided as a supplement to, and should be read in conjunction with, our unaudited financial statements, the accompanying notes to the financial statements (“Notes”) appearing elsewhere in this report and our Annual Report on Form 10-K for the year ended December 31, 2016 .
 
We supply high precision computer controlled metalcutting turning machines, grinding machines, vertical and horizontal machining centers, and repair parts related to those machines. The Company also engineers and supplies high precision, standard and specialty workholding devices, and other machine tool accessories. We believe our products are known for accuracy, reliability, durability and value. We are geographically diversified with manufacturing facilities in China, France, Germany, India, Switzerland, Taiwan, the United States (“U.S.”), and the United Kingdom (“U.K.”), with sales to most industrialized countries. Approximately 68% of our 2016 sales were to customers outside of North America, 71% of our 2016 products sold were manufactured outside of North America, and 68% of our employees as of December 31, 2016 were employed outside of North America. In the first half of 2017, approximately 69% of our sales were to customers outside of North America, 73% of our products sold were manufactured outside of North America, and, as of June 30, 2017, 68% of our employees were outside of North America.
 
Metrics on machine tool market activity monitored by our management include world machine tool shipments, as reported annually by Gardner Publications in the Metalworking Insiders Report, and metal-cutting machine orders, as reported by the Association of Manufacturing Technology, the primary industry group for U.S. machine tool manufacturers. Other closely followed U.S. market indicators are tracked to determine activity levels in U.S. manufacturing plants that are prospective customers for our products. One such measurement is the Purchasing Managers Index, as reported by the Institute for Supply Management. Another measurement is capacity utilization of U.S. manufacturing plants, as reported by the Federal Reserve Board. Similar information regarding machine tool shipments and economic indicators in foreign countries is published by trade associations, government agencies, and economic services in those countries.
 
Non-machine sales, which include collets, chucks, accessories, repair parts and service revenue, accounted for approximately 35% of overall sales through the second quarter of 2017 and are an important part of our business due to an installed base of thousands of machines, and the growing needs demanded by specialty workholding applications. In the past, sales of these products and services have not fluctuated on a year-to-year basis as significantly as the sales of our machines have from time to time, but demand for these products and services typically track the direction of the related machine metrics.
 
Other key performance indicators are geographic distribution of net sales (“sales”) and net orders (“orders”), gross profit as a percent of sales, income from operations, working capital changes, and debt level trends. In an industry where constant product technology development has led to an average model life of three to five years, effectiveness of technological innovation and development of new products are also key performance indicators.
 
We are exposed to financial market risk resulting from changes in interest and foreign currency rates. Global economic conditions and related disruptions within the financial markets have also increased our exposure to the possible liquidity and credit risks of our counterparties. We believe we have sufficient liquidity to fund our foreseeable business needs, including cash and cash equivalents, cash flows from operations, our bank financing arrangements, and equity financing arrangements.
 
We monitor the third-party depository institutions that hold our cash and cash equivalents. Our emphasis is primarily on safety of principal. Our cash and cash equivalents are diversified among counterparties to minimize exposure to any one of these entities.
 
We are subject to credit risks relating to the ability of counterparties of hedging transactions to meet their contractual payment obligations. The risks related to creditworthiness and non-performance has been considered in the fair value measurements of our foreign currency forward exchange contracts.
 
We expect that some of our customers and vendors may experience difficulty in maintaining the liquidity required to buy inventory or raw materials. We continue to monitor our customers’ financial condition in order to mitigate the risk associated with our ability to collect on our accounts receivable.
 

20


Foreign currency exchange rate changes can be significant to reported results for several reasons. Our primary competitors, particularly for the most technologically advanced products, are now largely manufacturers in Japan, Germany, Switzerland, Korea, and Taiwan, which causes the worldwide valuation of their respective currencies to be central to competitive pricing in all of our markets. The major functional currencies of our subsidiaries are the British Pound Sterling (“GBP”), Chinese Renminbi (“CNY”), Euro (“EUR”), New Taiwanese Dollar (“TWD”), and Swiss Franc (“CHF”). Under U.S. generally accepted accounting principles, results of foreign subsidiaries are translated into U.S. Dollars (“USD”) at the average exchange rate during the periods presented. Period-to-period changes in the exchange rate between their local currency and the USD may affect comparative data significantly. We also purchase computer controls and other components from suppliers throughout the world, with purchase costs reflecting currency changes.
 
For the three and six months ended June 30, 2017 , foreign currency fluctuations resulted in unfavorable currency translation impact of approximately $1.5 million and $3.0 million on sales when compared to the same periods in 2016 .

Results of Operations
 
Presented below is summarized selected financial data for the three and six months ended June 30, 2017 and 2016 (in thousands): 
 
 
Three Months Ended 
 June 30,
 
$
Change
 
%
Change
 
Six Months Ended 
 June 30,
 
$
Change
 
%
Change
 
 
2017
 
2016
 
 
 
2017
 
2016
 
 
Sales
 
$
78,197

 
$
70,186

 
$
8,011

 
11
 %
 
$
142,754

 
$
138,007

 
$
4,747

 
3
 %
Gross profit
 
26,629

 
23,553

 
3,076

 
13
 %
 
48,016

 
46,296

 
1,720

 
4
 %
% of sales
 
34.1
%
 
33.6
%
 
0.5

pts.
 
33.6
%
 
33.5
 %
 
0.1

pts.
Selling, general and administrative expenses
 
20,081

 
19,637

 
444

 
2
 %
 
38,103

 
40,230

 
(2,127
)
 
(5
)%
% of sales
 
25.7
%
 
28.0
%
 
(2.3
)
pts.
 
26.7
%
 
29.2
 %
 
(2.5
)
pts.
Research & development
 
3,777

 
3,369

 
408

 
12
 %
 
7,335

 
6,656

 
679

 
10
 %
Restructuring
 
542

 
226

 
316

 
140
 %
 
1,978

 
426

 
1,552

 
364
 %
Other expense (income), net
 
37

 
20

 
17

 
85
 %
 
192

 
(72
)
 
264

 
(367
)%
Income (loss) from operations
 
2,192

 
301

 
1,891

 
628
 %
 
408

 
(944
)
 
1,352

 
(143
)%
% of sales
 
2.8
%
 
0.4
%
 
2.4

pts.
 
0.3
%
 
(0.7
)%
 
1.0

pts.
Interest expense, net
 
66

 
63

 
3

 
5
 %
 
131

 
149

 
(18
)
 
(12
)%
Income (loss) before income taxes
 
2,126

 
238

 
1,888

 
793
 %
 
277

 
(1,093
)
 
1,370

 
(125
)%
Income tax (benefit) expense
 
(396
)
 
93

 
(489
)
 
(526
)%
 
(198
)
 
8

 
(206
)
 
(2,575
)%
Net income (loss)
 
$
2,522

 
$
145

 
$
2,377

 
1,639
 %
 
$
475

 
$
(1,101
)
 
$
1,576

 
(143
)%
% of sales
 
3.2
%
 
0.2
%
 
3.0

pts.
 
0.3
%
 
(0.8
)%
 
1.1

pts.

Sales .  The table below summarizes sales by each corresponding geographical region for the three and six months ended June 30, 2017 compared to the same period in 2016 (in thousands): 
 
Three Months Ended 
 June 30,
 
$
 
%
 
Six Months Ended 
 June 30,
 
$
 
%
 
2017
 
2016
 
Change
 
Change
 
2017
 
2016
 
Change
 
Change
Sales to customers in:
North America
$
24,220

 
$
20,694

 
$
3,526

 
17%
 
$
43,803

 
$
38,144

 
$
5,659

 
15%
Europe
22,240

 
22,242

 
(2
)
 
—%
 
39,942

 
46,084

 
(6,142
)
 
(13)%
Asia and other
31,737

 
27,250

 
4,487

 
16%
 
59,009

 
53,779

 
5,230

 
10%
Total
$
78,197

 
$
70,186

 
$
8,011

 
11%
 
$
142,754

 
$
138,007

 
$
4,747

 
3%
 
Sales for the three months ended June 30, 2017 were $78.2 million , an increase of $8.0 million , or 11% , compared to the same period in 2016 . The increase in sales was driven by higher demand in Asia and North America, partially offset by unfavorable foreign currency translation of approximately $1.5 million. Excluding the translation impact, the increase in sales would have been 14%.
 

21


Sales for the six months ended June 30, 2017 were $142.8 million , an increase of $4.7 million , or 3% , compared to the same period in 2016 . The increase in sales was driven by increases in North America and Asia machine sales, partially offset by decreases in machine sales in Europe and an unfavorable foreign currency translation of approximately $3.0 million. Excluding the translation impact, the increase in sales would have been 6%.
 
North America sales were $24.2 million and $43.8 million during the three and six months ended June 30, 2017 , respectively, an increase of $3.5 million , or 17% , and $5.7 million , or 15% , when compared to the same periods in 2016 .

Europe sales were $22.2 million and $39.9 million during the three and six months ended June 30, 2017 , respectively. Sales for the three months ended June 30, 2017 were flat compared to the prior year period. Sales for the six-month period ended June 30, 2017 decreased by $6.1 million or 13% due to first quarter weakness in the European industrial markets. Sales for the three and six months ended June 30, 2017 had unfavorable foreign currency translation of approximately $0.6 and $1.1 million, respectively.
 
Asia and other sales were $31.7 million and $59.0 million during the three and six months ended June 30, 2017 , respectively, an increase of $4.5 million , or 16% , and $5.2 million , or 10% , when compared to the same periods in 2016 . The sales increases over prior year in both three and six month comparative periods was due to a significant increase in machine sales which was partially offset by unfavorable foreign currency translation of approximately $0.9 million and $1.9 million, respectively.
 
Sales of machines accounted for approximately 67% and 65% of the consolidated sales for the three and six months ended June 30, 2017 and 66% for the three and six months ended June 30, 2016 , respectively. Sales of non-machine products and services, primarily consisting of collets, chucks, accessories, repair parts, and service revenue, accounted for approximately 33% and 35% of the consolidated sales for the three and six months ended June 30, 2017 and 34% for the three and six months ended June 30, 2016 .
 
Gross Profit.   Gross profit was $26.6 million , or 34% of sales for the three months ended June 30, 2017 , compared to $23.6 million , or 34% of sales for the same period in 2016 . The increase in gross profit was attributable to higher sales volume for the three months ended June 30, 2017 as compared to the same period in 2016 and a $0.2 million improvement due to incremental savings generated by the restructuring program initiated in late 2015.
 
Gross profit was $48.0 million or 34% of sales for the six months ended June 30, 2017 , compared to $46.3 million or 34% of sales for the same period in 2016 . The increase in gross profit was attributable to higher sales volume for the six months ended June 30, 2017 as compared to the same period in 2016 and a $0.5 million improvement due to incremental savings generated by the restructuring program initiated in late 2015.

Selling, General and Administrative Expenses. Selling, general and administrative (“SG&A”) expenses were $20.1 million , or 26% of sales for the three months ended June 30, 2017 , an increase of $0.4 million , or 2% , compared to $19.6 million , or 28% of sales for the three months ended June 30, 2016 . We incurred $1.2 million of unusual charges in the current quarter, primarily associated with our change in Chief Executive Officer (CEO). The prior year quarter included $0.4 million in costs associated with the Company’s strategic review process. Without the impact of these unusual costs, SG&A would have decreased by $0.4 million in the current quarter compared to the prior-year quarter.

SG&A expenses were $38.1 million , or 27% of sales for the six months ended June 30, 2017 , compared to $40.2 million , or 29% of sales for the six months ended June 30, 2016 . We incurred $1.3 million of unusual charges in the current six-month period, primarily associated with our change in CEO. The prior year six-month period included $1.1 million in costs associated with the Company’s strategic review process. Without the impact of these unusual costs, SG&A would have decreased by $2.3 million in the current six-month period compared to the prior-year period. This decrease in six-month period SG&A expenses was largely attributable to lower variable selling related expenses.
 
Restructuring. Restructuring expenses were $0.5 million and $2.0 million for the three and six months ended June 30, 2017, respectively. In March 2017, management initiated a strategic restructuring program in our MMS segment that is expected to be substantially completed in 2018. Restructuring expenses were $0.2 million and $0.4 million for the three and six months ended June 30, 2016, respectively. The 2016 expenses were related to the 2015 restructuring program.

Research and Development Expenses.  Research and Development ("R&D") expenses were $3.8 million , or 5% of sales for the three months ended June 30, 2017 , relatively flat compared to $3.4 million , or 5% of sales for the three months ended June 30, 2016 . R&D expenses were $7.3 million , or 5% of sales for the six months ended June 30, 2017 , compared to $6.7 million , or 5% of sales for the six months ended June 30, 2016 .

Income (Loss) Before Income Taxes .  As a result of the foregoing, income before income taxes was $2.1 million for the three months ended June 30, 2017 , compared to income before income taxes of $0.2 million for the same period in 2016 . For the six months

22


ended June 30, 2017 , income before income taxes was $0.3 million compared to loss before income taxes of $1.1 million for the same period in 2016 .

Income Taxes.  The income tax provision was a benefit of $0.4 million and $0.2 million for the three and six months ended June 30, 2017 , compared to an income tax provision expense of $0.1 million and $0.01 million for the same periods in 2016 . The effective tax rate was (18.6)% and (71.5)% for the three and six months ended June 30, 2017 , compared to 39.1% and (0.7)% for the same periods in 2016 , which differs from the U.S. statutory rate primarily due to the mix of earnings by country and by the non-recognition of tax benefits for certain entities in a loss position for which a full valuation allowance has been recorded. The tax benefit recorded during the three months ended June 30, 2017 is mainly driven by the release of an uncertain tax position due to the lapsing of the statute of limitations resulting in a tax benefit of $0.6 million.
 
Each quarter, an estimate of the full year tax rate is developed based upon anticipated annual results and an adjustment is made, if required, to the year-to-date income tax expense to reflect the full year anticipated effective tax rate.

We continue to maintain a valuation allowance on all or a portion of the tax benefits of our U.S., Canada, U.K., Germany, and Netherlands net deferred tax assets and we expect to continue to record a full valuation allowance on future tax benefits until an appropriate level of profitability is sustained in the respective jurisdiction.
 
Net Income (Loss).  As a result of the foregoing, net income for the three months ended June 30, 2017 was $2.5 million , or 3% of sales, compared to $0.1 million , or 0.2% of sales, for the same period in 2016 . Net income for the six months ended June 30, 2017 was $0.5 million , or 0.3% of sales, compared to net loss of $1.1 million , or (0.8)% of sales, for the same period in 2016 . Both basic and diluted income (loss) per share for the three and six months ended June 30, 2017 were $0.20 and $0.04 , compared to $0.01 and $(0.09) for the same periods in 2016 .

Business Segment Information — Comparison of the three and six months ended June 30, 2017 and 2016

Metalcutting Machine Solutions Segment (MMS) (in thousands):
 
Three Months Ended 
 June 30,
 
 
 
 
 
Six Months Ended 
 June 30,
 
 
 
 
 
2017
 
2016
 
$ Change
 
% Change
 
2017
 
2016
 
$ Change
 
% Change
Sales
$
62,016

 
$
54,359

 
$
7,657

 
14
%
 
$
110,848

 
$
106,630

 
$
4,218

 
4
%
Segment income (loss)
1,928

 
276

 
1,652

 
599
%
 
(741
)
 
(880
)
 
139

 
16
%
 
MMS sales were $62.0 million for the three months ended June 30, 2017 , an increase of $7.7 million , or 14% when compared to the corresponding period in 2016 . Increases in Asia and North America were partially offset by a decrease in Europe. For the six months ended June 30, 2017 , MMS sales were $110.8 million , an increase of $4.2 million , or 4% , when compared to the same period in 2016. Increases in Asia and North America were partially offset by a decrease in Europe and unfavorable foreign currency translation of approximately $2.8 million.

Segment income for the three months ended June 30, 2017 was $1.9 million , an increase of $1.7 million . The increase is due to increased sales volume, partially offset by restructuring charges of $0.5 million in the current period.

For the six months ended June 30, 2017 , segment loss was $0.7 million , an improvement of $0.1 million , or 16% , when compared to the segment loss in the same period of 2016. The volume related increases in gross profit and lower agent commissions of $1.7 million due to changes in channel mix, were largely offset by restructuring charges of $2.0 million in the current period.

23



Aftermarket Tooling and Accessories Segment (ATA)   (in thousands):
 
Three Months Ended 
 June 30,
 
 
 
 
 
Six Months Ended 
 June 30,
 
 
 
 
 
2017
 
2016
 
$ Change
 
% Change
 
2017
 
2016
 
$ Change
 
% Change
Sales
$
16,302

 
$
15,883

 
$
419

 
3
%
 
$
32,161

 
$
31,504

 
$
657

 
2
%
Segment income
2,745

 
1,641

 
1,104

 
67
%
 
5,031

 
3,495

 
1,536

 
44
%
 
ATA sales for the three months ended June 30, 2017 were $16.3 million , an increase of $0.4 million , or 3% , when compared to the corresponding period in 2016 . Increases in Europe were partially offset by decreases in other markets. ATA sales for the six months ended June 30, 2017 were $32.2 million, an increase of $0.7 million, or 2%, when compared to the corresponding period in 2016. Increases in North America and Europe were partially offset by decreases in Asia and unfavorable foreign currency translation of approximately $0.2 million.

Segment income for the three months ended June 30, 2017 was $2.7 million , a $1.1 million , or 67% increase from the prior year due to reduced manufacturing costs and operating expenses. Segment income for the six months ended June 30, 2017 was $5.0 million, a $1.5 million, or 44% increase from the prior year. ATA experienced higher volumes with improved absorption and reduced manufacturing costs, including $0.4 million of improvement generated by the 2015 restructuring program completed in late 2016.

Segment Summary For the Three and Six Months Ended June 30, 2017 and 2016 (in thousands):

 
Three Months ended June 30, 2017
 
Three Months Ended June 30, 2016
 
MMS
 
ATA
 
Inter-Segment
Eliminations
 
Total
 
MMS
 
ATA
 
Inter-Segment
Eliminations
 
Total
Sales
$
62,016

 
$
16,302

 
$
(121
)
 
$
78,197

 
$
54,359

 
$
15,883

 
$
(56
)
 
$
70,186

Segment income
1,928

 
2,745

 
 
 
4,673

 
276

 
1,641

 
 
 
1,917

Unallocated corporate
   expense
 

 
 

 
 

 
(2,481
)
 
 

 
 

 
 

 
(1,616
)
Interest expense, net
 

 
 

 
 

 
(66
)
 
 

 
 

 
 

 
(63
)
Other unallocated
   expense
 
 
 
 
 
 

 
 
 
 
 
 
 

Income before
   income taxes
 

 
 

 
 

 
$
2,126

 
 
 
 
 
 
 
$
238

 
Six Months Ended June 30, 2017
 
Six Months Ended June 30, 2016
 
MMS
 
ATA
 
Inter-Segment
Eliminations
 
Total
 
MMS
 
ATA
 
Inter-Segment
Eliminations
 
Total
Sales
$
110,848

 
$
32,161

 
$
(255
)
 
$
142,754

 
$
106,630

 
$
31,504

 
$
(127
)
 
$
138,007

Segment (loss) income
(741
)
 
5,031

 
 
 
4,290

 
(880
)
 
3,495

 

 
2,615

Unallocated corporate
   expense
 

 
 

 
 

 
(3,882
)
 
 

 
 

 
 

 
(3,559
)
Interest expense, net
 

 
 

 
 

 
(131
)
 
 

 
 

 
 

 
(149
)
Other unallocated
   expense
 
 
 
 
 
 

 
 
 
 
 
 
 

(Loss) income before
   income taxes
 

 
 

 
 

 
$
277

 
 
 
 
 
 
 
$
(1,093
)


24


Summary of Cash Flows for the Six Months Ended June 30, 2017 and 2016 (in thousands):  
 
 
Six Months Ended 
 June 30,
 
 
 
2017
 
2016
 
Net cash used in operating activities
 
$
(258
)
 
$
(6,039
)
 
Net cash used in investing activities
 
$
(952
)
 
$
(955
)
 
Net cash used in financing activities
 
$
(2,616
)
 
$
(2,579
)
 

During the six months ended June 30, 2017 , we used $0.3 million net cash from operating activities. The net cash used was the result of offsetting movements in operating results and net working capital. In the first half of 2017, total changes in operating assets and liabilities used $5.9 million, but was offset by sources from net income of $0.5 million, non-cash adjustments of $4.4 million for depreciation and amortization and $1.4 million for inventory impairment. The prior year cash used in operating activities of $6.0 million was the result of total changes in operating assets and liabilities of $8.9 million and a net loss of $1.1 million, partially offset by sources from non-cash adjustments of $4.1 million for depreciation and amortization.

Net cash used in investing activities was $1.0 million for the six months ended June 30, 2017 and 2016. The primary use of cash was for capital expenditures during these periods, which were made primarily for maintenance capital purchases.

Net cash flow used in financing activities was $2.6 million for the six months ended June 30, 2017 . Cash used was primarily attributable to $1.5 million of payments on long-term debt due to normal scheduled payment activity, $0.6 million of payments on short term borrowings and year-to-date dividends paid of $0.5 million .

Net cash flow used in financing activities was $2.6 million for the six months ended June 30, 2016 . Cash used for financing activities was primarily driven by $2.3 million of payments on long-term debt due to normal scheduled payment activity and year-to-date dividends paid of $0.5 million .


Liquidity and Capital Resources
 
We maintain financing arrangements with several financial institutions. These financing arrangements are in the form of long term loans, credit facilities, and lines of credit. The credit facilities allow us to borrow up to $76.4 million at June 30, 2017 and $74.7 million at December 31, 2016 , of which $54.3 million and $53.0 million , respectively, can be borrowed for working capital needs. As of June 30, 2017 and December 31, 2016 , $68.0 million and $67.1 million was available for borrowing under these respective arrangements, of which $53.7 million and $51.9 million , respectively, was available for working capital needs. Total consolidated borrowings outstanding were $4.7 million and $6.0 million at June 30, 2017 and December 31, 2016 , respectively. Additionally, we had borrowings under revolving credit facilities of $0.1 million and $0.7 million at June 30, 2017 and December 31, 2016 , respectively.
 
Our financing arrangements contain certain debt covenant requirements, including financial covenants, representations, affirmative and negative covenants, prepayment provisions and events of default. As of June 30, 2017 , we were in compliance with all of our debt covenants.
 
Our liquidity requirements primarily include funding for operations, including working capital requirements, and funding for capital investments and acquisitions. We expect to meet these requirements in the long term through cash provided by operating activities and availability under various credit facilities and other financing arrangements. Cash flows from operating activities are primarily driven by earnings before non-cash charges and change in working capital needs. During the six months ended June 30, 2017 , cash flows from operating activities and available cash were sufficient to fund our normal investment activities, primarily capital expenditures for property, plant and equipment and other productive assets.
 
We assess on an ongoing basis our portfolio of operations, as well as our financial and capital structures, to ensure we have sufficient capital and liquidity to meet our strategic objectives. As part of this process, from time to time we evaluate and pursue acquisition opportunities that we believe will enhance our strategic position.

25



Accounting Guidance Not Yet Adopted

We are currently assessing the financial impact to our consolidated financial statements of accounting guidance not yet adopted. For further information on accounting guidance not yet adopted, refer to Note 16. "New Accounting Standards" of the Consolidated Financial Statements.
 
Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Accordingly, there can be no assurance that our expectations will be realized. Such statements are based upon information known to management at this time. The Company cautions that such statements necessarily involve uncertainties and risk and deal with matters beyond the Company’s ability to control, and in many cases the Company cannot predict what factors would cause actual results to differ materially from those indicated. Among the many factors that could cause actual results to differ from those set forth in the forward-looking statements are fluctuations in the machine tool business cycles, changes in general economic conditions in the U.S. or internationally, the mix of products sold and the profit margins thereon, the relative success of the Company’s entry into new product and geographic markets, the Company’s ability to manage its operating costs, actions taken by customers such as order cancellations or reduced bookings by customers or distributors, competitors’ actions such as price discounting or new product introductions, governmental regulations and environmental matters, changes in the availability and cost of materials and supplies, the implementation of new technologies and currency fluctuations. Any forward-looking statement should be considered in light of these factors. The Company undertakes no obligation to revise its forward-looking statements if unanticipated events alter their accuracy.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.
 
There have been no material changes to our market risk exposures during the first six months of 2017 . For a discussion of our exposure to market risk, refer to Item 7A, Quantitative and Qualitative Disclosures About Market Risks, contained in our 2016 Annual Report on Form 10-K.
 

Item 4.  Controls and Procedures.
 
Management of the Company, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of June 30, 2017 , as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, and determined that these controls and procedures were effective.
 
There have been no changes in the Company’s internal control over financial reporting during the quarter ended June 30, 2017 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934.


26


PART II — OTHER INFORMATION
 
Item 1.          Legal Proceedings.
 
None.
 
Item 1A.       Risk Factors.
 
There is no change to the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .
 
Item 2.          Unregistered Sales of Equity Securities and Use of Proceeds.
 
None.
 
Item 3.          Defaults Upon Senior Securities.
 
None.
 
Item 4.          Mine Safety Disclosures.
 
Not Applicable.
 
Item 5.          Other Information.
 
None.

27


Item 6.
 
Exhibits.
 
 
 
3.1
 
Restated Certificate of Incorporation of Hardinge Inc. (conformed to reflect the Certificate of Amendment to the Restated Certificate of Incorporation, dated February 19, 2012 and the Certificate of Amendment to the Restated Certificate of Incorporation, dated May 3, 2017).

 
 
 
3.2
 
Amended and Restated By-Laws of Hardinge Inc. (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 16, 2017).
 
 
 
4.1
 
Specimen of certificate for shares of Common Stock, par value $.01 per share, of Hardinge Inc. (incorporated by reference to Exhibit 3 to Registrant’s Registration Statement on Form 8-A, filed with the Securities and Exchange Commission on May 19, 1995 (File No. 000-15760)).
 
 
 
10.1
 
Employment Agreement dated as of May 10, 2017, between Hardinge Inc. and Charles P. Dougherty.
 
 
 
10.2
 
Employment Offer Letter dated as of June 1, 2017, issued by Hardinge Inc. to Randall D. Bahr.
 
 
 
10.3
 
Non-qualified Option Agreement dated as of June 6, 2017, between Hardinge Inc. and Charles P. Dougherty.
 
 
 
10.4
 
Non-qualified Option Agreement dated as of June 6, 2017, between Hardinge Inc. and Charles P. Dougherty.
 
 
 
10.5
 
Schedule Required by Instruction 2 to Item 601 of Regulation S-K.
 
 
 
10.6
 
Consulting Agreement dated as of May 10, 2017, between Hardinge Inc. and Richard L. Simons.
 
 
 
31.1
 
Chief Executive Officer Certification pursuant to Rule 13a-15(e) and 15d-15(e), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
31.2
 
Chief Financial Officer Certification pursuant to Rule 13a-15(e) and 15d-15(e), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
32
 
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
101.INS
 
XBRL Instance Document
 
 
 
101.SCH
 
XBRL Taxonomy Schema Document
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document


28


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
HARDINGE INC.
 
 
Registrant
 
 
August 3, 2017
 
By:
/s/ Charles P. Dougherty
Date
 
 
Charles P. Dougherty
 
 
 
President and Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 
August 3, 2017
 
By:
/s/ Douglas J. Malone
Date
 
 
Douglas J. Malone
 
 
 
Senior Vice President and Chief Financial Officer
 
 
 
(Principal Financial Officer)


29
EXHIBIT 3.1
CONFORMED COPY TO REFLECT AMENDMENTS MADE THROUGH MAY 5, 2017

RESTATED CERTIFICATE OF INCORPORATION
-of-
HARDINGE INC.
Under Section 807 of the Business Corporation Law.

1.
The name of the Corporation is Hardinge Inc.
2.
The purposes for which it is to be formed are to acquire, buy, purchase, lease, or otherwise equip, maintain, and operate a general machine shop, to design and manufacture tools, machinery, boilers, engines, and all things made wholly or partly from metals, to do repairing, welding, brazing, stamping, and cutting and electrical work of all kinds, to engage in all kinds of mechanical and electrical engineering and manufacturing business; to apply for, acquire, buy, lease, sell, assign, pledge or otherwise acquire or dispose of letters patent issued by the United States or by any foreign country; and to acquire by purchase or otherwise, and to sell, assign, or pledge or license territorial rights authorizing the manufacture of patent articles, to acquire by purchase or otherwise licenses, privileges, inventions, trade-marks and trade-names used in connection with any article that this Corporation has the right to manufacture, buy or sell; and to grant licenses under letters patent of the United States or any foreign country to purchase, lease or otherwise acquire and to sell, mortgage or lease real property, whether improved or unimproved, or any interest therein, and to any amount, in the State of New York, or any state or territory of the United States or any foreign country; and to conduct and carry on its business or any branch thereof in any state or territory of the United States or in any foreign country, in conformity with the laws of said state, territory or foreign country; and to have and maintain in any said state, territory or foreign country a business office, plant or store; and to do and perform all and everything which may be necessary, advisable or suitable and proper for the conduct of business of said Corporation and for the purpose of carrying out the objects heretofore expressed, and to exercise all implied powers and rights in the conduct of the business which the Corporation may possess.
3.
The total number of shares which the Corporation may henceforth have is 22,000,000, all of which are to have a par value of $0.01 each, which shares shall be classified as follows:
2,000,000 shares of the par value of $0.01 each are to be Preferred Stock; and

20,000,000 shares of the par value of $0.01 each are to be a single class of common stock (the “Common Stock”).

4.
The relative voting, dividend, liquidation and other rights, preferences and limitations of the shares of each class are as follows:
I.
The Preferred Stock may be issued from time to time in one or more series, each such series to have the number of shares and designation, and the shares of each such series to have such relative rights, preferences or limitations, as the Board of Directors, subject to the limitations prescribed by law or provided herein, may from time to time fix, before issuance, by delivering an appropriate certificate of amendment to the Department of State pursuant to the Business Corporation Law of the State of New York. The authority of the Board of Directors with respect to each series shall include, but not be limited to, the fixing of the following:
(a)
The number of shares to constitute the series and the distinctive designation thereof;
(b)
The dividend rate on the shares of the series; whether dividends shall be cumulative, and, if so, from what date or dates;
(c)
Whether or not the shares of the series shall be redeemable and, if redeemable, the terms upon which the shares of the series may be redeemed and the premium, if any, over and above the par value thereof and any dividends accrued thereon which the shares of the series shall be entitled to receive upon the redemption thereof;
(d)
Whether or not the shares of the series shall be subject to the operation of a retirement or sinking fund to be applied to the purchase or redemption of such shares for retirement and, if such retirement or sinking fund be established, the annual amount thereof and the terms and provisions relative to the operation thereof;
(e)
Whether or not the shares of the series shall be convertible into shares of any class or classes of stock of the Corporation, with or without par value, or of any other series of the same class and, if convertible, the conversion price or prices or the rate at which such conversion may be made and the method, if any, of adjusting the same;
(f)
The rights of the shares of the series in the event of voluntary or involuntary liquidation, dissolution or winding-up of the Corporation;
(g)
The restrictions, if any, on the payment of dividends upon, and the making of the distributions to any class of stock ranking junior to the shares of the series, and the restrictions, if any, on the purchase or redemption of the shares of any such junior class;
(h)
Whether the series shall have voting rights, in addition to the voting rights provided by law, and, if so, the terms of such voting rights; and
(i)
Any other relative rights, preferences and limitations of the series.
II.
Holders of shares of Preferred Stock shall be entitled to receive, when and as declared by the Board of Directors, out of funds legally available for the payment of dividends, dividends at the rates fixed by the Board of Directors for the respective series, before any dividends shall be declared and paid, or set apart for payment, on any other class of stock of the Corporation ranking junior to the Preferred Stock either as to dividends or assets, with respect to the same dividend period.
III.
Whenever, at any time, dividends on the then outstanding Preferred Stock as may be required by the terms of the certificate creating the series representing the shares outstanding shall have been paid or declared and set apart for payment on the then outstanding Preferred Stock and after complying with all the provisions with respect to any retirement or sinking fund or funds for any series of Preferred Stock, the Board of Directors may, subject to the provisions of any certificate creating any series of Preferred Stock with respect to the payment of dividends on any other class or classes of stock, declare and pay dividends on the Common Stock, and the Preferred Stock shall not be entitled to share therein.
IV.
Upon any liquidation, dissolution or winding-up of the Corporation, after payment, if any is required, shall have been made in full to the Preferred Stock as provided in any certificate creating any series thereof, but not prior thereto, the Common Stock shall, subject to the respective terms and provisions, if any, of any such certificate, be entitled to receive any and all assets remaining to be paid or distributed, and the Preferred Stock shall not be entitled to share therein.
V.
No holder of Common Stock or any series of Preferred Stock shall, as such holder, have any preemptive or preferential right of subscription to any stock of any class of the Corporation or to any obligations convertible into any such stock or to any right of subscription to, or to any warrant or option for, the purchase of any stock, other than such, if any, as the Board of Directors of the Corporation in its discretion may determine from time to time.
VI.
The holders of the Common Stock shall have the right to vote on all questions to the exclusion of all other classes of stock, except as by law expressly provided or as otherwise expressly provided with respect to the holders of any other class or classes of stock.
VII.
Series B Preferred Stock : The designation and amount, relative rights, preferences and limitations of the shares of Series B Preferred Stock, par value $0.01 per share, as fixed by the Board of Directors of the Corporation, are as follows:
Section 1.     Designation and Amount . The shares of such series shall be designated as “Series B Preferred Stock” (the “Series B Preferred Stock”) and the number of shares constituting the Series B Preferred Stock shall be 200,000. Such number of shares may be increased or decreased by resolution of the Board of Directors; provided, that no decrease shall reduce the number of shares of Series B Preferred Stock to a number less than the number of shares then outstanding plus the number of shares reserved for issuance upon the exercise of outstanding options, rights or warrants or upon the conversion of any outstanding securities issued by the Corporation convertible into Series B Preferred Stock.
Section 2.     Dividends and Distributions .
(A)      Subject to the rights of the holders of any shares of any series of Preferred Stock (or any similar stock) ranking prior and superior to the Series B Preferred Stock with respect to dividends, the holders of shares of Series B Preferred Stock, in preference to the holders of Common Stock, par value $.01 per share (the “Common Stock”), of the Corporation, and of any other junior stock, shall be entitled to receive, when, as and if declared by the Board of Directors out of funds legally available for the purpose, quarterly dividends payable in cash on the first day of March, June, September and December in each year (each such date being referred to herein as a “Quarterly Dividend Payment Date”), commencing on the first Quarterly Dividend Payment Date after the first issuance of a share or fraction of a share of Series B Preferred Stock, in an amount per share (rounded to the nearest cent) equal to the greater of (a) $1 or (b) subject to the provision for adjustment hereinafter set forth, 100 times the aggregate per share amount of all cash dividends, and 100 times the aggregate per share amount (payable in kind) of all non-cash dividends or other distributions, other than a dividend payable in shares of Common Stock or a subdivision of the outstanding shares of Common Stock (by reclassification or otherwise), declared on the Common Stock since the immediately preceding Quarterly Dividend Payment Date or, with respect to the first Quarterly Dividend Payment Date, since the first issuance of any share or fraction of a share of Series B Preferred Stock. In the event the Corporation shall at any time declare or pay any dividend on the Common Stock payable in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the amount to which holders of shares of Series B Preferred Stock were entitled immediately prior to such event under clause (b) of the preceding sentence shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.
(B)      The Corporation shall declare a dividend or distribution on the Series B Preferred Stock as provided in paragraph (A) of this Section immediately after it declares a dividend or distribution on the Common Stock (other than a dividend payable in shares of Common Stock); provided that, in the event no dividend or distribution shall have been declared on the Common Stock during the period between any Quarterly Dividend Payment Date and the next subsequent Quarterly Dividend Payment Date, a dividend of $1 per share on the Series B Preferred Stock shall nevertheless be payable on such subsequent Quarterly Dividend Payment Date.
(C)      Dividends shall begin to accrue and be cumulative on outstanding shares of Series B Preferred Stock from the Quarterly Dividend Payment Date next preceding the date of issue of such shares, unless the date of issue of such shares is prior to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall begin to accrue from the date of issue of such shares, or unless the date of issue is a Quarterly Dividend Payment Date or is a date after the record date for the determination of holders of shares of Series B Preferred Stock entitled to receive a quarterly dividend and before such Quarterly Dividend Payment Date, in either of which events such dividends shall begin to accrue and be cumulative from such Quarterly Dividend Payment Date. Accrued but unpaid dividends shall not bear interest. Dividends paid on the shares of Series B Preferred Stock in an amount less than the total amount of such dividends at the time accrued and payable on such shares shall be allocated pro rata on a share-by-share basis among all such shares at the time outstanding. The Board of Directors may fix a record date for the determination of holders of shares of Series B Preferred Stock entitled to receive payment of a dividend or distribution declared thereon, which record date shall be not more than 60 days prior to the date fixed for the payment thereof.
Section 3.     Voting Rights . The holders of shares of Series B Preferred Stock shall have the following voting rights:
(A)      Subject to the provision for adjustment hereinafter set forth, each share of Series B Preferred Stock shall entitle the holder thereof to 100 votes on all matters submitted to a vote of the stockholders of the Corporation. In the event the Corporation shall at any time declare or pay any dividend on the Common Stock payable in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the number of votes per share to which holders of shares of Series B Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying such number by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.
(B)      Except as otherwise provided herein, in any other Certificate of Amendment creating a series of Preferred Stock or any similar stock, or by law, the holders of shares of Series B Preferred Stock and the holders of shares of Common Stock and any other capital stock of the Corporation having general voting rights shall vote together as one class on all matters submitted to a vote of stockholders of the Corporation.
(C)      Except as set forth herein, or as otherwise provided by law, holders of Series B Preferred Stock shall have no special voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock as set forth herein) for taking any corporate action.
Section 4.     Certain Restrictions .
(A)      Whenever quarterly dividends or other dividends or distributions payable on the Series B Preferred Stock as provided in Section 2 are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not declared, on shares of Series B Preferred Stock outstanding shall have been paid in full, the Corporation shall not:
(i)      declare or pay dividends, or make any other distributions, on any shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series B Preferred Stock;
(ii)      declare or pay dividends, or make any other distributions, on any shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series B Preferred Stock, except dividends paid ratably on the Series B Preferred Stock and all such parity stock on which dividends are payable or in arrears in proportion to the total amounts to which the holders of all such shares are then entitled;
(iii)      redeem or purchase or otherwise acquire for consideration shares of any stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series B Preferred Stock, provided that the Corporation may at any time redeem, purchase or otherwise acquire shares of any such junior stock in exchange for shares of any stock of the Corporation ranking junior (either as to dividends or upon dissolution, liquidation or winding up) to the Series B Preferred Stock; or
(iv)      redeem or purchase or otherwise acquire for consideration any shares of Series B Preferred Stock, or any shares of stock ranking on a parity with the Series B Preferred Stock, except in accordance with a purchase offer made in writing or by publication (as determined by the Board of Directors) to all holders of such shares upon such terms as the Board of Directors, after consideration of the respective annual dividend rates and other relative rights and preferences of the respective series and classes, shall determine in good faith will result in fair and equitable treatment among the respective series or classes.
(B)      The Corporation shall not permit any subsidiary of the Corporation to purchase or otherwise acquire for consideration any shares of stock of the Corporation unless the Corporation could, under paragraph (A) of this Section 4, purchase or otherwise acquire such shares at such time and in such manner.
Section 5.     Reacquired Shares . Any shares of Series B Preferred Stock purchased or otherwise acquired by the Corporation in any manner whatsoever shall be retired and canceled promptly after the acquisition thereof. All such shares shall upon their cancellation become authorized but unissued shares of Preferred Stock and may be reissued as part of a new series of Preferred Stock subject to the conditions and restrictions on issuance set forth herein, in the Certificate of Incorporation, or in any other Certificate of Amendment creating a series of Preferred Stock or any similar stock or as otherwise required by law.
Section 6.     Liquidation, Dissolution or Winding Up . Upon any liquidation, dissolution or winding up of the Corporation, no distribution shall be made (1) to the holders of shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series B Preferred Stock unless, prior thereto, the holders of shares of Series B Preferred Stock shall have received $100 per share, plus an amount equal to accrued and unpaid dividends and distributions thereon, whether or not declared, to the date of such payment, provided that the holders of shares of Series B Preferred Stock shall be entitled to receive an aggregate amount per share, subject to the provision for adjustment hereinafter set forth, equal to 100 times the aggregate amount to be distributed per share to holders of shares of Common Stock, or (2) to the holders of shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series B Preferred Stock, except distributions made ratably on the Series B Preferred Stock and all such parity stock in proportion to the total amounts to which the holders of all such shares are entitled upon such liquidation, dissolution or winding up. In the event the Corporation shall at any time declare or pay any dividend on the Common Stock payable in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the aggregate amount to which holders of shares of Series B Preferred Stock were entitled immediately prior to such event under the proviso in clause (1) of the preceding sentence shall be adjusted by multiplying such amount by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.
Section 7.     Consolidation, Merger, etc . In case the Corporation shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such case each share of Series B Preferred Stock shall at the same time be similarly exchanged or changed into an amount per share, subject to the provision for adjustment hereinafter set forth, equal to 100 times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged. In the event the Corporation shall at any time declare or pay any dividend on the Common Stock payable in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the amount set forth in the preceding sentence with respect to the exchange or change of shares of Series B Preferred Stock shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.
Section 8.     No Redemption . The shares of Series B Preferred Stock shall not be redeemable.
Section 9.     Rank . The Series B Preferred Stock shall rank, with respect to the payment of dividends and the distribution of assets, junior to all series of any other class of the Corporation’s Preferred Stock.
Section 10.     Amendment . The Certificate of Incorporation of the Corporation shall not be amended in any manner which would materially alter or change the powers, preferences or special rights of the Series B Preferred Stock so as to affect them adversely without the affirmative vote of the holders of at least two-thirds of the outstanding shares of Series B Preferred Stock, voting together as a single class.
1.
The office of the Corporation shall be located in the County of Chemung, New York, and the address to which the Secretary of State shall mail a copy of process in any action or proceeding against the Corporation, which may be served upon him, is P.O. Box 1507, Elmira, New York 14902.
2.
The duration of the Corporation shall be perpetual.
3.
Subject to the other provisions of this Certificate of Incorporation, the business of the Corporation shall be managed under the direction of its Board of Directors. The number of Directors constituting the Board of Directors shall be nine subject to increase or decrease from time to time as provided in the by-laws of the Corporation. Amendments of the by-laws by the shareholders shall require the affirmative vote of at least 75% of the outstanding shares of stock of the Corporation entitled to vote generally in the election of directors, voting as a single class. Each Director elected by shareholders at or after the 2017 annual meeting of shareholders shall hold office until the next annual meeting of shareholders and until his or her successor has been elected and qualified, subject, however, to prior death, resignation, retirement, disqualification or removal from office; provided , however , each Director elected by shareholders prior to the 2017 annual meeting of shareholders shall serve the term for which he or she was elected. Any and all vacancies in the Board of Directors, however occurring, including without limitation, by reason of any increase in size in the Board of Directors, or death, resignation, disqualification or removal of a Director, shall be filled solely by the election via an affirmative vote of a majority of the remaining Directors then in office, even if less than a quorum of the Board of Directors. Any director so elected shall serve until the next shareholder meeting held for the election of directors and until his or her successor has been elected and qualified. Any Director or the entire Board of Directors may be removed from office, only for cause, and only by the affirmative vote of the holders of at least 75% of the outstanding shares of stock of the Corporation entitled to vote generally in the election of directors, voting as a single class.
4.
The Secretary of State is designated as the agent of the Corporation upon whom process in any action or proceeding against it may be served.
5.
Business Combinations .
5.1
For the purposes of this Article 9:
1.
The term “beneficial owner” and correlative terms shall have the meaning as set forth in Rule 13d-3 under the Securities Exchange Act of 1934, as amended, or any similar successor Rule. Without limitation and in addition to the foregoing, any shares of Voting Stock of this Corporation which any Major Stockholder has the right to vote or to acquire (i) pursuant to any agreement, (ii) by reason of tenders of shares by stockholders of the Corporation in connection with or pursuant to a tender offer made by such Major Stockholder (whether or not any tenders have been accepted, but excluding tenders which have been rejected), or (iii) upon the exercise of conversion rights, warrants, options or otherwise, shall be deemed “beneficially owned” by such Major Stockholder.
2.
The term “Business Combination” shall mean:
a.
any merger or consolidation (whether in a single transaction or a series of related transactions, including a series of separate transactions with a Major Stockholder, any Affiliate or Associate thereof or any Person acting in concert therewith) of this Corporation or any Subsidiary with or into a Major Stockholder or of a Major Stockholder into this Corporation or a Subsidiary;
b.
any sale, lease, exchange, transfer, distribution or other disposition, including without limitation, a mortgage, pledge or any other security device to or with a Major Stockholder by the Corporation or any of its Subsidiaries (in a single transaction or a series of related transaction) of all, substantially all or any Substantial Part of the assets of this Corporation or a Subsidiary (including, without limitation, any securities of a Subsidiary);
c.
the purchase, exchange, lease or other acquisition by the Corporation or any of its Subsidiaries (in a single transaction or a series of related transactions) of all, substantially all or any Substantial Part of the assets or business of a Major Stockholder;
d.
the issuance of any securities, or of any rights, warrants or options to acquire any securities, of this Corporation or a Subsidiary to a Major Stockholder or the acquisition by this Corporation or a Subsidiary of any securities, or of any rights, warrants or options to acquire any securities, of a Major Stockholder;
e.
any reclassification of Voting Stock, recapitalization or other transaction (other than a redemption in accordance with the terms of the security redeemed) which has the effect, directly or indirectly, of increasing the proportionate amount of Voting Stock of the Corporation or any Subsidiary thereof which is beneficially owned by a Major Stockholder;
f.
any plan or proposal for any partial or complete liquidation, spin off, split off or split up of the Corporation or any Subsidiary thereof proposed directly or indirectly by or on behalf of a Major Stockholder; and
g.
any agreement, contract or other arrangement providing for any of the transactions described herein.
3.
The term “Continuing Director” shall mean (i) a person who was a member of the Board of Directors of this Corporation immediately prior to the time that any then existing Major Stockholder became a Major Stockholder or (ii) a person elected to the Board of Directors at the 1986 Annual Meeting of Stockholders or (iii) a person designated (before initially become a director) as a Continuing Director by a majority of the then Continuing Directors. All references to a vote of the Continuing Directors shall mean a vote of the total number of Continuing Directors of the Corporation.
4.
The term “Major Stockholder” shall mean any Person which, together with its “Affiliates” and “Associates” (as defined in Rule 12-b-2 of the Securities Exchange Act of 1934, as amended, or any similar successor Rule) and any Person acting in concert therewith, is the beneficial owner of 10% or more of the votes held by the holders of the outstanding shares of the Voting Stock of this Corporation, and any Affiliate or Associate of a Major Stockholder, including a Person acting in concert therewith. The term “Major Stockholder” shall not include a Subsidiary of this Corporation, nor a Person who was a Major Stockholder on May 20, 1986.
5.
The term “Person” shall mean any individual, corporation, partnership or other person, group or entity (other than the Corporation, any Subsidiary of the Corporation or a trustee holding stock for the benefit of employees of the Corporation or its Subsidiaries, or any one of them, pursuant to one or more employee benefit plans or arrangements). When two or more Persons act as a partnership, limited partnership, syndicate, association or other group for the purpose of acquiring, holding or disposing of shares of stock, such partnerships, syndicate, associate or group will be deemed a “Person”.
6.
The term “Subsidiary” shall mean any business entity 50% or more of which is beneficially owned by the Corporation.
7.
The term “Substantial Part”, as used in reference to the assets of the Corporation, of any Subsidiary or of any Major Stockholder means assets having a value of more than 10% of the total consolidated assets of the Corporation and its Subsidiaries as of the end of the Corporation’s most recent fiscal year ending prior to the time the determination is made.
8.
The term “Voting Stock”, shall mean the Common Stock and any other securities entitled to vote upon any action to be taken in connection with any Business Combination including stock or other securities convertible into Voting Stock.
5.2
Notwithstanding any other provisions of these Articles of Incorporation and except as set forth in 9.3 of this Article 9, neither the Corporation nor any Subsidiary shall be party to a Business Combination unless the Business Combination was approved by at least 75% of the outstanding Voting Stock of this Corporation and by at least 75% of the outstanding Voting Stock beneficially owned by stockholders other than any Major Stockholder, provided , however , that such 75% vote of the outstanding stockholders and such 75% vote of the stockholders other than the Major Stockholder shall not be required and such Business Combination shall only required such affirmative vote, if any, of the stockholders as is required by law and any other provision of this Certificate of Incorporation, if
1.
The Business Combination was approved by the Board of Directors of the Corporation prior to the Major Stockholder involved in the Business Combination becoming a Major Stockholder; or
2.
The Major Stockholder involved in the Business Combination sought and obtained the unanimous prior approval of the Board of Directors to become a Major Stockholder and the Business Combination was approved by a majority of the Continuing Directors; or
3.
The Business Combination was approved by at least 75% of the Continuing Directors of the Corporation.
5.3
During the time a Major Stockholder exists, a resolution to voluntarily dissolve the Corporation shall be adopted only upon the vote by at least 75% of the outstanding Voting Stock of this Corporation and by at least 75% of the outstanding Voting Stock beneficially owned by stockholders other than any major Stockholder, providing , however , that such 75% vote of the outstanding stockholders and such 75% vote of the stockholders other than the Major Stockholder shall not be required and such Business Combination shall require only such affirmative vote, if any, of the stockholders as is required by law and any other provision of this Certificate of Incorporation if such dissolution was approved by the vote of at least 75% of the Continuing Directors of the Corporation.
5.4
The Board of Directors of the Corporation, when evaluating a Business Combination or the dissolution of the Corporation, shall give due consideration to all relevant factors, including without limitation the social and economic effects of such action or transaction upon the Corporation, its stockholders, employees, customers, vendors, suppliers and other constituencies, and on the communities in which the Corporation operates or is located.
5.5
As to any particular transaction, the Continuing Directors shall have the power and duty to determine, on the basis of information known to them:
1.
The amount of Voting Stock beneficially held by any Person;
2.
Whether a Person is an Affiliate or Associate of another;
3.
Whether a Person is acting in concert with another;
4.
Whether the assets subject to any Business Combination constitute a “Substantial Part: as herein defined;
5.
Whether a proposed transaction is subject to the provisions of this Article 9; and 12
6.
Any other matters with respect to which a determination is required under this Article 9. Any such determination shall be conclusive and binding for all purposes of this Article 9.
5.6
The affirmative vote of the Board of Directors, the Continuing Directors, or the Voting Stock required by this Article 9 is in addition to the vote otherwise required by law or this Certificate of Incorporation.
5.7
Any amendment, change or repeal of this Article 9 or any other amendment of this Certificate of Incorporation which would have the effect of modifying or permitting circumvention of the provisions of this Article 9 shall require approval by at least 75% of the outstanding voting Stock of the Corporation and at least 75% of the outstanding Voting Stock beneficially owned by stockholders other than any Major Stockholder, provided , however , that such 75% vote of the outstanding stockholders and such 75% vote of the stockholders other than the Major Stockholder shall not be required and such Business Combination shall only require such affirmative vote, if any, of the stockholders as is required by law and any other provision of this Certificate of Incorporation if such amendment, change, repeal or other amendment was approved by the vote of at least 75% of the Continuing Directors of the Corporation.
5.8
The requirements and restrictions of this Article 9 relating to Business Combinations are in addition to the requirements and restrictions of Section 912 of the Business Corporation Law relating to Business Combinations but shall not limit any requirements or restrictions of said Section 912 relating to Business Combinations.
6.
The provisions of Section 912 of the Business Corporation Law shall apply to this Corporation.
7.
Liability of Directors . A director of the Corporation shall not be liable to the Corporation or its stockholders for damages for any breach of duty as a director, except to the extent that such exemption for liability or limitation thereof is not permitted under the Business Corporation Law as the same exists or may hereafter be amended. Any repeal or modification of this Article 11 by the stockholders of the Corporation shall not affect adversely any right or protection of a director of the Corporation existing at the time of such repeal or modification.


- 1 -


HARDINGE INC.
EMPLOYMENT AGREEMENT


This EMPLOYMENT AGREEMENT (the “ Agreement ”) is dated as of May 10, 2017, between HARDINGE INC. , a New York corporation (the “ Company ”) and Charles P. Dougherty (the “ Executive ”).

WHEREAS, the Company desires to engage the Executive, as a full-time executive employee, to provide services to the Company pursuant to the terms of this Agreement, and the Executive desires to accept such employment.

NOW, THEREFORE, in consideration of the covenants and agreements hereinafter set forth, the parties agree as follows:

1.     EFFECTIVE DATE

This Agreement shall become effective, and the Executive’s employment with the Company shall commence, on May 10, 2017 (the “ Effective Date ”).

2.     EMPLOYMENT; DUTIES AND TERM

2.1     General . The Company hereby employs the Executive as, and the Executive agrees to serve as, President and Chief Executive Officer, upon the terms and conditions specified in this Agreement. The Executive shall perform such duties and services for the Company as may be determined from time to time by the Board of Directors of the Company (the “ Board ”), provided that such duties and services shall be consistent in all material respects with the Executive’s position as President and Chief Executive Officer of the Company. The Executive agrees to serve the Company faithfully and to the best of his ability under the direction of the Board.

2.2     Exclusive Services . Except as may otherwise be approved in advance by the Board, the Executive shall devote his full working time throughout the Employment Term (as defined in Section 2.3) to the performance of services for the Company. The Executive shall render his services exclusively to the Company during the Employment Term, and shall use his best efforts, judgment and energy to improve and advance the business and interests of the Company in a manner consistent with the duties of his position. During the Employment Term, the Executive will not be employed with any other person or entity, or be self-employed, without the prior written approval of the Board.

2.3     Term of Employment . The Executive’s employment under this Agreement shall commence as of the Effective Date and shall terminate on the earlier of (i) the second anniversary of the Effective Date (the “ Second Anniversary Date ”) or (ii) termination of the Executive’s employment pursuant to this Agreement. At least 120 days prior to the Second Anniversary Date, the Board will initiate a discussion with the Executive regarding continuation of the Executive’s employment after the Second Anniversary Date. If the Executive’s employment with the Company continues after the Second Anniversary Date and the Company and the Executive have not agreed in writing to renew this Agreement or entered into a new employment agreement that supersedes this Agreement, the Executive’s continuing employment with the Company will be “at will.” For the purposes of this Agreement, “ Employment Term ” means the period beginning on the Effective Date and ending on the date that Executive’s employment with the Company terminates for any reason.

2.4     Board Appointment . Not later than 60 days following the Effective Date, the Board will consider appointment of the Executive to the Board. If the Executive is serving as a member of the Board at the time of termination of his Employment (for any reason), then the Executive will resign from the Board as of the effective date of such termination.

3.     COMPENSATION

3.1     Base Salary . Commencing on the Effective Date, the Executive shall be paid an annual base salary (“ Base Salary ”) in the amount of $500,000.00, payable in accordance with the Company’s payroll practices. Subject to the Executive’s rights under Section 5.2, Base Salary is subject to increase or decrease, from time to time, in the sole and absolute discretion of the Board.

3.2     Annual Review . The Executive’s performance and Base Salary shall be reviewed by the Board not less often than annually.

3.3     Bonus and Additional Compensation . The Executive shall be eligible to receive awards under the Company’s cash incentive and stock incentive compensation plans. The Executive’s annual target award under the Company’s cash incentive and stock incentive compensation plans shall be 100% of Base Salary, with a threshold-maximum of 50% to 150% of Base Salary. Awards under the Company’s cash incentive plan and stock incentive plan shall be determined at the discretion of the Board, and may be subject to attainment of performance targets and objectives determined by the Board.

3.4     Reimbursement of Expenses . Unless otherwise agreed to by the Executive and the Company, the Company shall reimburse the Executive for reasonable travel and other business expenses incurred by him in the fulfillment of his duties hereunder upon presentation by the Executive of an itemized account of such expenditures, in accordance with Company practices and policies.

3.5     Initial Option Grant . Within thirty (30) days following the Effective Date, the Executive will receive an award of 150,000 non-qualified stock options under the Company’s stock incentive compensation plan. The stock options will be subject to vesting requirements described on Exhibit A .

3.6     Recoupment . The Executive agrees that the compensation provided by the Company under this Agreement or otherwise is subject to recoupment or clawback under any applicable Company clawback or recoupment policy that is generally applicable to the Company’s senior executives, as may be in effect from time to time, or as required by law.

4.     EMPLOYEE BENEFITS

The Executive shall, during his employment under this Agreement, be included to the extent eligible thereunder in all employee benefit plans, programs or arrangements (including plans, programs or arrangements providing for retirement benefits, disability benefits, health and life insurance, or vacation and paid holidays) which shall be established by the Company for, or made available to, its senior executives generally. A description of the benefit plans, programs and arrangements applicable to the Executive as of the Effective Date is attached as Exhibit B . The Executive will be provided an automobile allowance in the amount of $1,000 per month, and not less than four (4) weeks vacation per calendar year.

5.     TERMINATION OF EMPLOYMENT

5.1     Termination Events .

5.1.1.     By the Company . The Company may terminate the Executive’s employment at any time for Cause (as hereinafter defined), without Cause, or upon the Executive’s Permanent Disability (as hereinafter defined).

5.1.2.     By the Executive . The Executive may terminate his employment at any time for Good Reason (as hereinafter defined) or without Good Reason.

5.2     Termination Without Cause; Resignation for Good Reason .

5.2.1 Severance Benefit . If, prior to the Second Anniversary Date, the Executive’s employment is terminated by the Company without Cause, or the Executive resigns from his employment for Good Reason, the Company shall continue to pay the Executive the Base Salary (at the rate in effect immediately prior to such termination) for twelve (12) months (such period being referred to hereinafter as the “ Severance Period ”). The payments shall occur in installments in the same amount in effect immediately prior to such termination and at the same regular payment intervals as the Executive’s Base Salary was being paid on the Effective Date and such installments shall be deemed a series of separate payments within the meaning of Treas. Reg. §1.409A-2(b)(2)(iii). Installments which in the aggregate do not exceed Executive’s Base Salary payable over 6 months shall be paid in a lump sum within 60 days following Executive’s termination of employment. The remaining installments, if any, shall be paid in regular payment intervals with the first such installment paid on the first payment date occurring on or after the day following the 6-month anniversary of the Executive’s termination of employment. In addition, during the Severance Period, the Executive (and his eligible dependents) shall be entitled to continue to participate in the group health insurance plan the Company provides to its executive employees (or, if the Executive is not entitled to participate in any such plan under the terms thereof, in a comparable substitute arrangement provided by the Company) at the Company’s expense, provided, however, that for the first six months following the Executive’s termination of employment, the Executive shall pay the premiums of such plan to the extent that the payment of such premiums by the Company would have constituted gross income to the Executive. The Company shall reimburse the Executive for any premiums or other expenses incurred by the Executive with respect to his participation and that of any of his dependents in such plan. The Executive shall have no further right to receive any other compensation or benefits after such termination or resignation of employment except as determined in accordance with the terms of the employee benefit plans or programs of the Company. In the event of the Executive’s death during the Severance Period, Base Salary continuation payments under this Section 5.2.1 shall continue to be made during the remainder of the Severance Period to the beneficiary designated in writing for this purpose by the Executive or, if no such beneficiary is specifically designated, to the Executive’s estate.

5.2.2 Termination of Severance Benefit . If, during the Severance Period, the Executive breaches his obligations under Section 6 of this Agreement, the Company may, upon written notice to the Executive and after allowing the Executive a reasonable opportunity to dispute the occurrence of a breach, terminate the Severance Period and cease to make any further payments or provide any benefits described in Section 5.2.1.

5.2.3 Release . The Company’s obligation to make the Base Salary continuation payments and provide health insurance benefits described in Section 5.2.1 shall be subject to the following conditions: (i) within twenty-one (21) days after the effective date of termination or resignation, the Executive shall have executed and delivered to the Company a Termination Agreement and Release (“ Release ”) in the form of Exhibit C attached hereto, and (ii) the Release shall not have been revoked by the Executive during the revocation period specified therein. If the Executive fails to deliver a fully executed Release to the Company before expiration of such twenty-one (21) day period, or such release is revoked as permitted therein, then the Company will have no obligation to make any of the payments or provide any of the benefits specified in Section 5.2.1.

5.3     Termination for Cause; Resignation Without Good Reason . If, prior to the Second Anniversary Date, the Executive’s employment is terminated by the Company for Cause, or the Executive resigns from his employment hereunder other than for Good Reason, the Executive shall be entitled only to payment of his Base Salary as then in effect through and including the date of termination or resignation. The Executive shall have no further right to receive any other compensation or benefits after such termination or resignation of employment, except as determined in accordance with the terms of the employee benefit plans or programs of the Company.

5.4     Cause . Termination for “ Cause ” shall mean termination of the Executive’s employment by the Company because of:

(i)    any act or omission that constitutes a breach by the Executive of any of his obligations under this Agreement or any Company policy or procedure and failure to cure such breach after notice of, and a reasonable opportunity to cure, such breach;

(ii)    the continued willful failure or refusal of the Executive to substantially perform the duties reasonably required of him as an employee of the Company;

(iii)    an act of moral turpitude, dishonesty or fraud by, or criminal conviction (excluding non-felony convictions relating solely to vehicle and traffic offenses) of, the Executive which in the determination of the Board would render his continued employment by the Company damaging or detrimental to the Company;

(iv)    any material misappropriation of Company property by the Executive; or

(v)    any other willful misconduct by the Executive which is materially injurious to the financial condition or business reputation of, or is otherwise materially injurious to, the Company.

5.5     Good Reason . For purposes of this Agreement, “ Good Reason ” shall mean the occurrence of one or more of the following events provided that, the Executive shall give the Company a written notice, within 45 days following the initial occurrence of the event, describing the event that the Executive claims to be Good Reason and stating the Executive’s intention to terminate employment unless the Company takes appropriate corrective action:

(i)    a decrease in the Executive’s Base Salary other than a decrease not exceeding 10% which is part of a general decrease in base salary for substantially all of the Company’s senior executives;

(ii)    a failure by the Company to pay material compensation due and payable to the Executive in connection with his employment;

(iii)    a change in the Executive’s position or title or the Company’s failure to assign to the Executive duties that are generally consistent with the Executive’s position and title;

(iv)    a material diminution in benefits provided by the Company to the Executive except for a diminution applicable to substantially all of the Company’s senior executives;

(v)    a failure or refusal of any successor company to assume the Company’s obligations under this Agreement;

(vi)    the Company’s material breach of any material term of this Agreement;

(vii)    the Company’s failure to offer to renew this Agreement, on substantially the same terms for a renewal period of not less than two years, at least 90 days prior to the Second Anniversary Date;

(viii)    a failure by the Board (or the applicable committee of the Board) to recommend to the Company’s stockholders the election or re-election of the Executive to serve as a member of the Board; or

(ix)    any change in reporting structure resulting in the Executive not being a direct report to the Board.

The Company shall have 30 days from the date of receipt of the written notice from the Executive stating his claim of Good Reason in which to take appropriate corrective action. If the Company does not cure the Good Reason during such period, the Executive’s employment will terminate as of the end of such 30-day period.

5.6     Death or Disability . In the event of termination of employment by reason of death or Permanent Disability, the Executive (or his estate, as applicable) shall be entitled to Base Salary and benefits through the date of termination. Other benefits shall be determined in accordance with the benefit plans maintained by the Company, and the Company shall have no further obligation hereunder. For purposes of this Agreement, “ Permanent Disability ” means a physical or mental disability or infirmity of the Executive that prevents the normal performance of substantially all his material duties as an employee of the Company, which disability or infirmity shall exist for any continuous period of 180 days.

6.     CONFIDENTIALITY; NONSOLICITATION AND NONCOMPETITION

6.1     Confidentiality . The Executive covenants and agrees with the Company that he will not any time during the Employment Term and thereafter, except in performance of his obligations to the Company hereunder or with the prior written consent of the Company, directly or indirectly, disclose any secret or confidential information that he may learn or has learned by reason of his association with the Company or any of its subsidiaries. The term “ confidential information ” includes information not previously made generally available to the public or to the trade by the Company’s management, with respect to the Company’s or any of its subsidiaries’ or affiliates’ products, facilities, applications and methods, trade secrets and other intellectual property, systems, procedures, manuals, confidential reports, product price lists, customer lists, technical information, financial information (including the revenues, costs or profits associated with any of the Company’s products), business plans, prospects or opportunities, but shall exclude any information which the Company intentionally makes generally available to the public or is generally known in the industry or industries in which the Company operates other than as a result of disclosure by the Executive in violation of his agreements under this Section 6.1. The Executive will be released of his obligations under this Section 6.1 to the extent the Executive is required to disclose under any applicable laws, regulations or directives of any government agency, tribunal or authority having jurisdiction in the matter or under subpoena or other process of law provided that the Executive provides the Company with prompt written notice of such requirement.

6.2     Acknowledgment of Company Assets . The Executive acknowledges that the Company, at the Company’s expense, has acquired, created and maintains, and will continue to acquire, create and maintain, significant goodwill with its (and its subsidiaries) current and prospective customers, vendors and employees, and that such goodwill is valuable property of the Company (and its subsidiaries). The Executive further acknowledges that to the extent such goodwill will be generated through the Executive’s efforts, such efforts will be funded by the Company and the Executive will be fairly compensated for such efforts. The Executive acknowledges that all goodwill developed by the Executive relative to the Company’s (and its subsidiaries) customers, vendors and employees shall be the sole and exclusive property of the Company and shall not be personal to the Executive. Accordingly, in order to afford the Company reasonable protection of such goodwill and of the Company’s (and its subsidiaries) confidential information, the Executive agrees as follows:

6.2.1.     Nonsolicitation; Non-Interference . For so long as the Executive is employed by the Company, and continuing for two years after if termination of employment for any reason, the Executive shall not, directly or indirectly, as a sole proprietor, member of a partnership, stockholder or investor, officer or director of a corporation, or as an employee, associate, consultant or agent of any person, partnership, corporation or other business organization or entity: (i) solicit or endeavor to entice away from the Company or any of its subsidiaries any person or entity who is, or, during the then most recent 12-month period, was employed by, or had served as an agent or key consultant of or contractor to the Company or any of its subsidiaries; (ii) solicit or endeavor to entice away from the Company or any of its subsidiaries any person or entity who is, or was within the then most recent 12-month period, a customer (or reasonably anticipated to become a customer) of the Company or any of its subsidiaries; or (iii)  interfere with the business relations between the Company (or any subsidiary) and any customer, partner, affiliate, supplier or vendor of the Company (or any subsidiary)  or persuade or encourage or attempt to persuade or encourage any customer, partner, affiliate, supplier or vendor of the Company (or any subsidiary) to cease doing business with the Company (or any subsidiary) or to engage in any activity competitive with the Company (or any subsidiary).

6.2.2.     No Competing Employment . For so long as the Executive is employed by the Company, and continuing for one year after termination of employment for any reason, the Executive shall not, directly or indirectly, as a sole proprietor, member of a partnership, stockholder or investor (other than a stockholder or investor owning not more than a 1% interest), officer or director of a corporation, or as an employee, associate, consultant or agent of any person, partnership, corporation or other business organization or entity other than the Company, render any service to or in any way be affiliated with a competitor (or any person or entity that is reasonably anticipated to the general knowledge of the Executive to become a competitor) of the Company or any of its subsidiaries. The Executive acknowledges and agrees that the Company conducts business throughout the world, that the Company’s legitimate and protectable business interests are throughout the world, and therefore this Section 6.2.2 is intended to prohibit competitive activities by the Executive throughout the world.

6.3     Exclusive Property . The Executive confirms that all confidential information is and shall remain the exclusive property of the Company. All business records, and documents (whether in paper or electronic media) kept or made by Executive relating to the business of the Company shall be and remain the property of the Company. Upon termination of the Executive’s employment with the Company for any reason, the Executive promptly deliver to the Company all of the following that are in the Executive’s possession or under his control: (i) all computers, telecommunication devices and other tangible property of the Company and its affiliates, and (ii) all documents and other materials, in whatever form, which include confidential information or which otherwise relate in whole or in part to the present or prospective business of the Company or its subsidiaries, including but not limited to, drawings, graphs, charts, specifications, notes, reports, memoranda, and computer disks and tapes, and all copies thereof; provided, however, the Executive shall be permitted to retain copies of this Agreement and written performance evaluations pertaining solely to the Executive.

6.4     Injunctive Relief . Without intending to limit the remedies available to the Company, the Executive acknowledges that a breach of any of the covenants contained in this Section 6 may result in material and irreparable injury to the Company or its affiliates or subsidiaries for which there is no adequate remedy at law, that it will not be possible to measure damages for such injuries precisely and that, in the event of such a breach or threat thereof, the Company shall be entitled to seek a temporary restraining order and/or a preliminary or permanent injunction restraining the Executive from engaging in activities prohibited by this Section 6 or such other relief as may be required specifically to enforce any of the covenants in this Section 6. If for any reason, it is held that the restrictions under this Section 6 are not reasonable or that consideration therefore is inadequate, such restrictions shall be interpreted or modified to include as much of the duration and scope identified in this Section 6 as will render such restrictions valid and enforceable.

6.5     Communication to Third Parties . The Executive agrees that Company shall have the right to communicate the terms of this Section 6 to any third parties, including but not limited to, any prospective employer of the Executive. The Company waives any right to assert any claim for damages against Company or any officer, employee or agent of Company arising from such disclosure of the terms of this Section 6.

6.6     Independent Obligations . The provisions of this Section 6 shall be independent of any other provision of this Agreement. The existence of any claim or cause of action by the Executive against the Company, whether predicated on this Agreement or otherwise, shall not constitute a defense of the enforcement of this Section 6 by the Company.

6.7     Non-Exclusivity . The Company’s rights and the Executive’s obligations set forth in this Section 6 are in addition to, and not in lieu of, all rights and obligations provided by applicable statutory or common law.

7.     CERTAIN PAYMENTS

Notwithstanding anything in this Agreement to the contrary, if any amounts due to the Executive under this Agreement and any other plan or program of the Company constitute a “parachute payment” (as defined in Section 280G(b)(2) of the Internal Revenue Code of 1986, as amended (the “ Code ”)), then the aggregate of the amounts constituting the parachute payment shall be reduced to an amount that will equal three times his “base amount” (as defined in Section 280G(b)(3) of the Code) less $1.00. The determination to be made with respect to this Section 7 shall be made by an accounting firm jointly selected by the Company and the Executive and paid by the Company, and which may be the Company’s independent auditors.

8.     MISCELLANEOUS .

8.1     Notices . All notices or communications hereunder shall be in writing, addressed as follows:

To the Company:

Hardinge Inc.
One Hardinge Drive
Elmira, New York 14902-1507
Telecopier No. (607) 734-2353
Attention: Chairman of the Board

To the Executive:

Charles P. Dougherty
1471 Parsons Lane
Lower Gwynedd, Pennsylvania 19002

All such notices shall be conclusively deemed to be received and shall be effective, (i) if sent by hand delivery, upon receipt, (ii) if sent by telecopy or facsimile transmission, upon confirmation of receipt by the sender of such transmission, or (iii) if sent by registered or certified mail, on the fifth day after the day on which such notice is mailed.

8.2     Severability . Each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision will be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement.

8.3     Assignment . The rights and obligations of this Agreement shall bind and inure to the benefit of any successor of the Company by reorganization, merger or consolidation, or any assignee of all or substantially all of the Company’s business and properties. Neither this Agreement nor any rights hereunder shall be assignable or otherwise subject to hypothecation by the Executive.

8.4     Entire Agreement . This Agreement represents the entire agreement of the parties and shall supersede any and all previous contracts, arrangements or understandings between the Company and the Executive relating to the subject matter hereof. This Agreement may be amended at any time by mutual written agreement of the parties hereto.

8.5     Withholding . The payment of any amount pursuant to this Agreement shall be subject to applicable withholding and payroll taxes, and such other deductions as may be required under the applicable law or Company’s employee benefits plans, if any.

8.6     Governing Law . This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York applicable to contracts executed in and to be performed entirely within that state.


[Signature page follows]

IN WITNESS WHEREOF, the Company has caused this Agreement to be duly executed and the Executive has hereunto set his hand, as of the day and year first above written.

HARDINGE INC.


By_______________________________
Name:
Title:


__________________________________
Charles P. Dougherty


State of New York        )
: ss.
County of Chemung        )

On the ____ day of May, 2017, before me, the undersigned, a Notary Public in and for said state, personally appeared ______________________, residing at ____________________________________________, the ________ of HARDINGE INC., personally known to me, or proved to me on the basis of satisfactory evidence, to be the individual whose name is subscribed to the within instrument, and he acknowledged to me that he executed the same in his capacity and that, by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument on behalf of said corporation.

___________________________________
Notary Public

State of ____________    )
: ss.
County of __________    )

On the ____ day of May, 2017, before me, the undersigned, personally appeared Charles P. Dougherty, personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and he acknowledged to me that he executed the same in his capacity, and that by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument.

___________________________________
Notary Public

NBca/fy
Doc #01-3032444.8

EXHIBIT A

INITIAL STOCK OPTION GRANT (150,000 OPTIONS)


●    75,000 options subject to time vesting:

●    37,500 options vest on two year anniversary of Effective Date, provided Executive is then employed by the Company

●    37,500 options vest on three year anniversary of the Effective Date, provided Executive is then employed by the Company


●    75,000 options subject to performance vesting:

●    performance criteria to be determined prior to option grant; will include long term and short term parameters


EXHIBIT B

FULL-TIME EMPLOYEE BENEFITS SUMMARY
EFFECTIVE JANUARY 1, 2017

Health and Dental Insurance – Excellus Blue Cross Blue Shield
Employee cost: $125.12/month individual or $329.04/month family coverage.
Eligibility: First of the month after 30 days of employment.
Health insurance: Covers hospitalization, medical, and prescription drug with a $1300 deductible for individual or a $2600 deductible for family coverage and 80% coinsurance after the deductible is met. Annual out-of-pocket maximum of $3000 for individual or $6000 for family coverage.
Health savings account (HSA): To assist with paying the deductible, the company contributes to a HSA $675 for individual or $1350 for family coverage for the year – pro-rated for employees hired after January 1 st . Employees may also contribute their own money on a pre-tax basis to the HSA.
Dental insurance: Covers preventative and basic restorative services at 100% and major restorative services at 50%. Annual deductible of $50 for individual or $150 for family on non-preventative services. Maximum annual benefit of $1250. Orthodontia for children under age 19 covered at 50% to a lifetime maximum of $1500.

401(k) Retirement Savings Plan – Vanguard
Eligibility: Date of hire for employee-paid contributions; semi-annual (January 1 st or July 1 st ) enrollment after one year of service for employer-paid contributions.
An automatic pre-tax 401(k) payroll deduction in the amount of 3% of gross pay starts within 30 days of hire unless the employee elects to change the amount or opt out. The employee may defer up to the IRS annual maximum, which for 2017 is $18,000, plus an additional $6,000 catch-up if over age 50.
The company matches 25 cents per dollar on the first 4% that the employee contributes, up to a 1% total match with immediate vesting.
The company contributes a 4% non-elective contribution whether the employee is contributing or not, which vests over six years.

Group Term Life Insurance
Eligibility: Date of hire.
The company pays the full cost of a life insurance policy equal to one times the employee’s base annual salary which doubles in the event of an accidental death.
Employees are able to buy additional guaranteed-issue supplemental group term life insurance for themselves, their spouse, and their dependent children at group rates through payroll deduction.

Disability Insurance
The company pays the full cost of New York State mandated short-term disability insurance for all employees. This plan pay $170 per week for the first six months of disability.
On the first of the month after one year of service, employees are eligible for long-term disability insurance (LTD). The company pays the full cost of LTD insurance. LTD insurance pays 60% of base salary after the employee has been out of work for six months and may pay for the duration of the disability up to age 65.

Paid Time Off
The company observes 11 paid holidays each year.
Employees are eligible for vacation time based on length of service.




EXHIBIT C

HARDINGE INC.
TERMINATION AGREEMENT AND RELEASE

In consideration of the payments and benefits to be provided to me by Hardinge Inc. (the “ Company ”) pursuant to Section 5.2.1 of the Employment Agreement between the Company and me dated _______ __, 2017 (the “ Employment Agreement ”), I agree as follows:

1. Termination . My employment with the Company is terminated effective ____________ and I will not thereafter apply for employment with the Company.
2.      Release . On behalf of myself and my heirs, successors, executors, administrators, trustees, legal representatives, agents and assigns, I fully and forever release and discharge the Company, its subsidiaries, divisions and affiliates and its and all of their predecessors, successors, assigns, directors and officers (collectively “ Released Parties ”) from any and all claims, demands, suits, causes of action, obligations, promises, damages, fees, covenants, agreements, attorneys’ fees, debts, contracts and torts of every kind whatsoever, known or unknown, at law or in equity, foreseen or unforeseen, which against the Released Parties I ever had, now have or which I may have for, upon or by reason of any matter, cause or thing whatsoever relating to or arising from my employment with the Company or the termination thereof, specifically including, but not limited to, all claims under the following: the Civil Rights Acts of 1866, 1871, 1964 and 1991; the Age Discrimination in Employment Act of 1967; the Older Workers’ Benefit Protection Act of 1990; the Americans with Disabilities Act; the Equal Pay Act; the Employee Retirement Income Security Act; the Worker Adjustment Retraining Notification Act; the Family and Medical Leave Act; the National Labor Relations Act; the Occupational Safety and Health Act; the New York State Human Rights Law; the New York City Human Rights Law; the New York State Labor Law; §§ 120 and 241 of the New York State Workers’ Compensation Law; any contract of employment, express or implied; and any and all other federal, state or local laws, rules or regulations.
I hereby waive the right to receive any personal relief (i.e. monetary or equitable relief) as a result of any lawsuit or other proceeding brought by the EEOC or any other governmental agency, based on or related to any of the matters from which I have released the Released Parties. I also will take all actions necessary, if any, now or in the future, to make this Release effective.

The foregoing release shall not operate to release the Company from its obligations to make payments and provide benefits as provided under Section 5.2.1 of the Employment Agreement.

In connection with the foregoing release (i) I acknowledge that the payments and benefits under Section 5.2.1 of the Employment Agreement are good and sufficient consideration to which I would not otherwise be entitled but for my execution and delivery to the Company of this instrument, (ii) I acknowledge that I have been advised by the Company to consult with an attorney before signing this instrument, (iii) the Company has allowed me at least twenty-one (21) days from the date I first receive this instrument to consider it before being required to sign it and return it to the Company, and (iv) I may revoke this instrument, in its entirety, within seven (7) days after signing it by delivering written notice of such revocation to the Company on or before 5:00 p.m. on the seventh day of such revocation period.

IN WITNESS WHEREOF, the undersigned has executed this instrument as of the ____ day of ___________.



                        
    



NBca/fy
Doc #01-3032444.8








HARDINGEGROUP.JPG

Hardinge Inc.
One Hardinge Drive
Elmira, NY 14902-1507 USA

p. 607.734.2281
sales 800.843.8801
sales fax 607.734.8819

www.hardinge.com


June 1, 2017

Dear Randy,
I am pleased to extend the following offer to you for the position of Senior Vice President, Corporate Development for Hardinge Inc. reporting to me. Your effective start date will be June 3rd, 2017. The following details the compensation and benefits as part of this offer:

1.
Commencing on the effective date the Executive shall be paid an annual Base Salary of $275,000, payable in accordance with the Company's payroll practices.

2.
Executive shall be included to the extent eligible thereunder in all employee benefit plans, programs, or arrangements (including plans, programs, or arrangements providing for retirement benefits, disability benefits, health and life insurance, or vacation and paid holidays) which shall be established by the Company for, or made available to, its senior executives generally.

3.
The Executive will be provided an automobile allowance in the amount of $1,000 per month, and not less than 3 weeks' vacation per calendar year.

4.
The Executive shall be eligible to receive awards under the Company's Cash Incentive and Stock Incentive Compensation plans. The Executive1s annual target award under the Company1s Cash Incentive and Stock Incentive Compensation plans shall be 50% of Base Salary. Awards under the Company's Cash Incentive Plan and Stock Incentive Plan shall be determined at the discretion of the Board, and may be subject to attainment of performance targets and objectives determined by the Board.

5.
Within (30) Days following the Effective Start date, the Executive will receive an Initial Option Grant of 75,000 non-qualified stock options under the Company's stock incentive compensation plan. The stock options will be subject to the following vesting requirements:
18,750 options vest on two year anniversary of Effective Start date, provided Executive is then employed by the Company
18,750 options vest on three year anniversary of the Effective Start date, provided Executive is then employed by the Company
37,500 options subject to performance vesting:
o
performance criteria to be determined prior to option grant; will include long term and short term parameters




We look forward to you joining the Hardinge executive leadership team!



Regards,
Charles P. Dougherty
President I Chief Executive Officer



HARDINGE INC.
AMENDED AND RESTATED
2011 INCENTIVE STOCK PLAN

NONQUALIFIED OPTION AGREEMENT

This NONQUALIFIED OPTION AGREEMENT (the “ Agreement ”) is dated as of June 6, 2017 (“ Effective Date ”), by and between HARDINGE INC. , a New York corporation (the “ Company ”) and Charles P. Dougherty (the “ Participant ”).

W I T N E S S E T H:

WHEREAS, the Hardinge Inc. Amended and Restated 2011 Incentive Stock Plan (the “ Plan ”) provides for the grant of Nonqualified Options in accordance with the terms and conditions of the Plan;

WHEREAS, the Compensation Committee (“ Committee ”) of the Board of Directors of the Company (the “ Board ”) has, pursuant to the terms of the Plan, determined that the Participant should be granted a Nonqualified Option (the “ Option ”)

NOW, THEREFORE, the Company and the Participant agree as follows:

1.     Incorporation of Plan; Capitalized Terms . The terms and conditions of the Plan are incorporated by reference herein. Capitalized terms used but not defined in this Agreement shall have the meanings ascribed to such terms in the Plan.

2.     Grant of Stock Option . The Company hereby grants to the Participant this Option to purchase the total number of shares of the common stock of Hardinge Inc., par value $.01 per share set forth below (the “ Shares ”) at the exercise price per share set forth below (the “ Exercise Price ”), subject to all of the terms of this Agreement and the Plan. This Option shall be a Nonqualified Option and is not intended to qualify as an “incentive stock option” within the meaning of Section 422 of the Code. The Exercise Price is equal to or greater than the fair market value of one share of the common stock of Hardinge Inc., par value $.01 per share on the date of grant of the Option set forth below (“ Date of Grant ”).

Number of Shares Subject to Option:
75,000 shares of Common Stock
Exercise Price Per Share:
$12.04
Date of Grant:
June 6, 2017
Expiration Date:
June 5, 2027
Type of Stock Option:
Nonqualified Option

3.     Vesting; Time of Exercise . Subject to the terms of this Agreement, the Option shall become vested and exercisable in accordance with the following terms:

(a)     Vesting .

(i)    fifty percent (50%) of the Shares subject to the Option shall become vested and exercisable on the second year anniversary of the Date of Grant; and

(ii)    the remaining fifty percent (50%) of the Shares subject to the Option shall become vested and exercisable on the third year anniversary of the Date of Grant.

(b)    Except as otherwise provided by this Agreement and/or under the Plan, this Option shall expire and shall be no longer be exercisable on the Expiration Date.

4.     Method of Exercising Option . The Option may be exercised by providing written notice to the Company signed by the Participant at the Company’s office located at One Hardinge Drive, Elmira, New York 14902-1507, Attention: Chief Financial Officer. The required notice shall state the number of Shares as to which the Participant is electing to exercise the Option and the address to which the Company shall deliver the certificate or certificates representing the Shares acquired hereunder (to the extent such Shares shall be evidenced by one or more certificates). The Participant may not exercise the Option with respect to less than one hundred (100) Shares unless such lesser number of Shares represents the balance of shares of Common Stock that remain subject to Option. In the event that any person other than the Participant seeks to exercise the Participant’s Option privileges, such person shall provide evidence satisfactory to the Company and its counsel of such person’s right to exercise the Participant’s Option privileges.

5.     Payment of Option Price . The option price shall be payable at the time the Option is exercised in cash or, at the discretion of the Company, in whole or in part in the form of shares of the Company’s Common Stock already owned by the Participant (based on the fair market value of the Common Stock on the date the Option is exercised). No Shares shall be issued until full payment therefor has been made.

6.     Tax Obligations . The Company shall be entitled to withhold, or otherwise collect from the Participant, the amount of any tax attributable to any amount payable or Shares deliverable following the exercise of the Option after giving the Participant notice as far in advance as practicable. The Participant may elect, subject to approval by the Company, to have Shares withheld by the Company in satisfaction of such taxes, or to deliver other shares of Common Stock owned by the Participant in satisfaction of such taxes. To the extent the Participant is subject to Section 16(b) of the Securities Exchange Act of 1934, as amended, the Company may impose such other conditions on the Participant’s election as it deems necessary.

7.     Nontransferability . Only the Participant may exercise the Option during the Participant’s lifetime and, in the limited circumstances described in Section 8 of this Agreement, by the Participant’s duly appointed legal representative. Except as is contemplated in Section 8 of this Agreement, no assignment or transfer of the Option, or of the rights represented thereby, whether voluntary or involuntary, by operation of law or otherwise shall vest in the assignee or transferee any interest or right herein whatsoever, but immediately upon such assignment or transfer, the Option shall terminate and be null and void and of no effect.

8.     Death of Participant . Upon the death of the Participant, Option privileges shall apply only to the extent such Option was immediately exercisable at the time of death of the Participant. To the extent the Option is exercisable upon death of the Participant, the Option may be exercised by the Participant’s duly appointed legal representative only as to that portion of the Option that was immediately exercisable as of the date of Participant’s death and such portion of the Option shall remain exercisable for a period of three (3) years following the date of death of the Participant. The Committee, in its discretion, may provide that any portion of the Option that is not exercisable as of the date of death of the Participant may become exercisable in accordance with a schedule to be determined by the Committee. Such privileges shall expire unless exercised by the Participant’s duly appointed legal representative within such period of time as determined by the Committee but in no event later than the date of expiration of the Option.

9.     Retirement or Termination . Upon Retirement or termination of employment of the Participant for reasons other than those described in Section 11 of this Agreement, Option privileges shall apply only to that portion of the Option immediately exercisable as of the date of such Retirement or termination. The Committee, however, in its discretion, may provide on a case-by-case basis that any portion of the Option that is not exercisable as of the date of such Retirement or termination may become exercisable in accordance with a schedule to be determined by the Committee. The portion of the Option exercisable upon the Retirement of the Participant shall remain exercisable for three (3) years after Retirement. The portion of the Option exercisable upon termination for reasons other than Retirement or those described in Section 11 of this Agreement shall remain exercisable for three (3) months after such termination.

10.     Change in Control . In accordance with Section 18 of the Plan, in the event of a Change of Control, any portion of the Option which is not exercisable and vested prior to the Change of Control shall become fully exercisable and vested as of the date the Change in Control is determined to have occurred by the Company.

11.     Forfeiture of Option . Unless the Company shall have determined otherwise, the Participant shall forfeit all privileges with respect to that portion of the Option not immediately exercisable upon the occurrence of any of the following events:

(a)    the Participant is Terminated for Cause;

(b)    the Participant voluntarily terminates his employment other than by Retirement after attainment of age 55;

(c)    the Participant engages in Competition with the Company or any Affiliate; and

(d)    the Participant engages in any activity or conduct contrary to the best interests of the Company or any Affiliate, as determined by the Company in its sole discretion.

To the extent any portion of the Option is immediately exercisable upon the occurrence of the preceding events, such portion of the Option shall remain exercisable for seven days after the occurrence of such event unless the Committee in its sole discretion shall provide the portion of the Option shall remain exercisable for a longer period.

12.     No Rights as Shareholder . The Participant shall have no rights as a shareholder with respect to any of the Shares subject to the Option until the Shares have been issued to the Participant, whether as evidenced by one or more certificates or by registry in book-entry form with the Company following the exercise of the Option.

13.     Acknowledgments of Participant . The Participant acknowledges and agrees that a copy of the Plan has been made available for his review by the Company and represents and warrants that he is familiar with the terms and provisions thereof and hereby accepts this Option subject to all the terms and provisions thereof. The Participant acknowledges that, in accordance with the terms of Section 5 of the Plan, the Committee shall:

(a)    administer and shall have full power to construe and interpret the Plan;

(b)    prescribe, amend and rescind rules and regulations relating to the Plan; and

(c)    make all other determinations and take all other actions that the Committee believes reasonable and proper, including the power to delegate responsibility to others to assist the Committee in administering the Plan.

The determinations of the Committee shall be made in accordance with its judgment as to the best interests of the Company and its stockholders and in accordance with the purposes of the Plan. In the case of any dispute, disagreement or matter of interpretation arising under this Agreement or the Plan, as the case may be, the Committee shall render the final decision and/or determination with respect to such dispute, disagreement or matter of interpretation. The Committee’s decisions and/or determinations shall in all cases be conclusive and final. To the extent this Agreement contemplates that: the taking of certain actions (or the refraining from taking of certain actions) is subject to the discretion of the Company or otherwise requires the approval of the Company or determinations as to certain matters are to be made by the Company, the Participant acknowledges and agrees that the Committee shall be empowered and authorized to act on behalf of the Company with respect to such matters.

14.     Governing Law . This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York without regard to its conflict of law principles.

15.     Interpretation . To the extent the phrase “portion of the Option” is used in this Agreement, such phrase may relate to, as the context dictates: (a) a portion of the Shares subject to the Option and/or (b) all of the Shares subject to the Option.

[ the remainder of this page is intentionally left blank ]


IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized officer, and the Participant, to evidence his consent and approval of all the terms hereof, has duly executed this Agreement as of the Effective Date.

COMPANY:

HARDINGE INC.



By: _______________________________
Benjamin L. Rosenzweig
Chairman, Compensation Committee of
Board of Directors


PARTICIPANT:



_______________________________
Charles P. Dougherty






HARDINGE INC.
AMENDED AND RESTATED
2011 INCENTIVE STOCK PLAN

NONQUALIFIED OPTION AGREEMENT

This NONQUALIFIED OPTION AGREEMENT (the “ Agreement ”) is dated as of June 6, 2017 (“ Effective Date ”), by and between HARDINGE INC. , a New York corporation (the “ Company ”) and Charles P. Dougherty (the “ Participant ”).

W I T N E S S E T H:

WHEREAS, the Hardinge Inc. Amended and Restated 2011 Incentive Stock Plan (the “ Plan ”) provides for the grant of Nonqualified Options in accordance with the terms and conditions of the Plan;

WHEREAS, the Compensation Committee (“ Committee ”) of the Board of Directors of the Company (the “ Board ”) has, pursuant to the terms of the Plan, determined that the Participant should be granted a Nonqualified Option (the “ Option ”)

NOW, THEREFORE, the Company and the Participant agree as follows:

1.     Incorporation of Plan; Capitalized Terms . The terms and conditions of the Plan are incorporated by reference herein. Capitalized terms used but not defined in this Agreement shall have the meanings ascribed to such terms in the Plan.

2.     Grant of Stock Option . The Company hereby grants to the Participant this Option to purchase the total number of shares of the common stock of Hardinge Inc., par value $.01 per share set forth below (the “ Shares ”) at the exercise price per share set forth below (the “ Exercise Price ”), subject to all of the terms of this Agreement and the Plan. This Option shall be a Nonqualified Option and is not intended to qualify as an “incentive stock option” within the meaning of Section 422 of the Code. The Exercise Price is equal to or greater than the fair market value of one share of the common stock of Hardinge Inc., par value $.01 per share on the date of grant of the Option set forth below (“ Date of Grant ”)

Number of Shares Subject to Option:
75,000 shares of Common Stock
Exercise Price Per Share:
$12.04
Date of Grant:
June 6, 2017
Expiration Date:
June 5, 2027
Type of Stock Option:
Nonqualified Option

3.     Vesting; Time of Exercise . Subject to the terms of this Agreement, the Option shall become vested and exercisable in accordance with the following terms:

(a)     Vesting; Performance Milestones . The Company and Participant acknowledge and agree that the vesting of the Option shall be dependent on the completion of certain milestones associated with the economic performance of the Company, as shall be mutually agreed upon by the Committee and the Participant from time to time (collectively, “ Performance Milestones ”) The Company and Participant acknowledge and agree that the Performance Milestones shall consist of Company goals associated with short-term economic performance metrics and long-term economic performance metrics.

(b)    Except as otherwise provided by this Agreement and/or under the Plan, this Option shall expire and shall be no longer be exercisable on the Expiration Date.

4.     Method of Exercising Option . The Option may be exercised by providing written notice to the Company signed by the Participant at the Company’s office located at One Hardinge Drive, Elmira, New York 14902-1507, Attention: Chief Financial Officer. The required notice shall state the number of Shares as to which the Participant is electing to exercise the Option and the address to which the Company shall deliver the certificate or certificates representing the Shares acquired hereunder (to the extent such Shares shall be evidenced by one or more certificates). The Participant may not exercise the Option with respect to less than one hundred (100) Shares unless such lesser number of Shares represents the balance of shares of Common Stock that remain subject to Option. In the event that any person other than the Participant seeks to exercise the Participant’s Option privileges, such person shall provide evidence satisfactory to the Company and its counsel of such person’s right to exercise the Participant’s Option privileges.

5.     Payment of Option Price . The option price shall be payable at the time the Option is exercised in cash or, at the discretion of the Company, in whole or in part in the form of shares of the Company’s Common Stock already owned by the Participant (based on the fair market value of the Common Stock on the date the Option is exercised). No Shares shall be issued until full payment therefor has been made.

6.     Tax Obligations . The Company shall be entitled to withhold, or otherwise collect from the Participant, the amount of any tax attributable to any amount payable or Shares deliverable following the exercise of the Option after giving the Participant notice as far in advance as practicable. The Participant may elect, subject to approval by the Company, to have Shares withheld by the Company in satisfaction of such taxes, or to deliver other shares of Common Stock owned by the Participant in satisfaction of such taxes. To the extent the Participant is subject to Section 16(b) of the Securities Exchange Act of 1934, as amended, the Company may impose such other conditions on the Participant’s election as it deems necessary.

7.     Nontransferability . Only the Participant may exercise the Option during the Participant’s lifetime and, in the limited circumstances described in Section 8 of this Agreement, by the Participant’s duly appointed legal representative. Except as is contemplated in Section 8 of this Agreement, no assignment or transfer of the Option, or of the rights represented thereby, whether voluntary or involuntary, by operation of law or otherwise shall vest in the assignee or transferee any interest or right herein whatsoever, but immediately upon such assignment or transfer, the Option shall terminate and be null and void and of no effect.

8.     Death of Participant . Upon the death of the Participant, Option privileges shall apply only to the extent such Option was immediately exercisable at the time of death of the Participant. To the extent the Option is exercisable upon death of the Participant, the Option may be exercised by the Participant’s duly appointed legal representative only as to that portion of the Option that was immediately exercisable as of the date of Participant’s death and such portion of the Option shall remain exercisable for a period of three (3) years following the date of death of the Participant. The Committee, in its discretion, may provide that any portion of the Option that is not exercisable as of the date of death of the Participant may become exercisable in accordance with a schedule to be determined by the Committee. Such privileges shall expire unless exercised by the Participant’s duly appointed legal representative within such period of time as determined by the Committee but in no event later than the date of expiration of the Option.

9.     Retirement or Termination . Upon Retirement or termination of employment of the Participant for reasons other than those described in Section 11 of this Agreement, Option privileges shall apply only to that portion of the Option immediately exercisable as of the date of such Retirement or termination. The Committee, however, in its discretion, may provide on a case-by-case basis that any portion of the Option that is not exercisable as of the date of such Retirement or termination may become exercisable in accordance with a schedule to be determined by the Committee. The portion of the Option exercisable upon the Retirement of the Participant shall remain exercisable for three (3) years after Retirement. The portion of the Option exercisable upon termination for reasons other than Retirement or those described in Section 11 of this Agreement shall remain exercisable for three (3) months after such termination.

10.     Change in Control . In accordance with Section 18 of the Plan, in the event of a Change of Control, any portion of the Option which is not exercisable and vested prior to the Change of Control shall become fully exercisable and vested as of the date the Change in Control is determined to have occurred by the Company.

11.     Forfeiture of Option . Unless the Company shall have determined otherwise, the Participant shall forfeit all privileges with respect to that portion of the Option not immediately exercisable upon the occurrence of any of the following events:

(a)    the Participant is Terminated for Cause;

(b)    the Participant voluntarily terminates his employment other than by Retirement after attainment of age 55;

(c)    the Participant engages in Competition with the Company or any Affiliate; and

(d)    the Participant engages in any activity or conduct contrary to the best interests of the Company or any Affiliate, as determined by the Company in its sole discretion.

To the extent any portion of the Option is immediately exercisable upon the occurrence of the preceding events, such portion of the Option shall remain exercisable for seven days after the occurrence of such event unless the Committee in its sole discretion shall provide the portion of the Option shall remain exercisable for a longer period.

12     No Rights as Shareholder . The Participant shall have no rights as a shareholder with respect to any of the Shares subject to the Option until the Shares have been issued to the Participant, whether as evidenced by one or more certificates or by registry in book-entry form with the Company following the exercise of the Option.

13.     Acknowledgments of Participant . The Participant acknowledges and agrees that a copy of the Plan has been made available for his review by the Company and represents and warrants that he is familiar with the terms and provisions thereof and hereby accepts this Option subject to all the terms and provisions thereof. The Participant acknowledges that, in accordance with the terms of Section 5 of the Plan, the Committee shall:

(a)    administer and shall have full power to construe and interpret the Plan;

(b)    prescribe, amend and rescind rules and regulations relating to the Plan; and

(c)    make all other determinations and take all other actions that the Committee believes reasonable and proper, including the power to delegate responsibility to others to assist the Committee in administering the Plan.

The determinations of the Committee shall be made in accordance with its judgment as to the best interests of the Company and its stockholders and in accordance with the purposes of the Plan. In the case of any dispute, disagreement or matter of interpretation arising under this Agreement or the Plan, as the case may be, the Committee shall render the final decision and/or determination with respect to such dispute, disagreement or matter of interpretation. The Committee’s decisions and/or determinations shall in all cases be conclusive and final. To the extent this Agreement contemplates that: the taking of certain actions (or the refraining from taking of certain actions) is subject to the discretion of the Company or otherwise requires the approval of the Company or determinations as to certain matters are to be made by the Company, the Participant acknowledges and agrees that the Committee shall be empowered and authorized to act on behalf of the Company with respect to such matters.

14.     Governing Law . This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York without regard to its conflict of law principles.

15.     Interpretation . To the extent the phrase “portion of the Option” is used in this Agreement, such phrase may relate to, as the context dictates: (a) a portion of the Shares subject to the Option and/or (b) all of the Shares subject to the Option.

[ the remainder of this page is intentionally left blank ]


IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized officer, and the Participant, to evidence his consent and approval of all the terms hereof, has duly executed this Agreement as of the Effective Date.

COMPANY:

HARDINGE INC.



By: _______________________________
Benjamin L. Rosenzweig
Chairman, Compensation Committee of
Board of Directors


PARTICIPANT:



_______________________________
Charles P. Dougherty




Exhibit 10.5

Schedule Required by Instruction 2 to 601
of Regulation S-K

Hardinge Inc. (the “Company”) entered into (i) a Nonqualified Option Agreement, dated as of June 6, 2017 with Charles P. Dougherty (the agreement is featured as Exhibit 10.4 to the Quarterly Report on Form 10-Q) which contemplates that the vesting of the option shall be subject to the completion of certain milestones associated with the economic performance of the Company, (the “Performance Milestone Option Agreement”) and (ii) a Nonqualified Option Agreement, dated as of June 6, 2017 with Charles P. Dougherty (the agreement is featured as Exhibit 10.3 to the Quarterly Report on Form 10-Q) which contemplates that the vesting of the option shall occur in accordance with a time-based schedule (the “Time Vesting Option Agreement”). The Company has also entered into two Nonqualified Option Agreements, dated as of June 6, 2017 with Randall D. Bahr (collectively, the “Bahr Option Agreements”). Except as noted below, one of the Bahr Option Agreements is substantially similar in all material respects to the Performance Milestone Option Agreement and the other Bahr Option Agreement is substantially similar in all material respects to the Time Vesting Option Agreement.

The only material difference between the Performance Milestone Option Agreement and the corresponding Bahr Option Agreement is the number of shares of common stock of Hardinge Inc., par value $.01 per share (the “Common Stock”) that is subject to each option agreement as set forth below:

Number of Shares of Common Stock
Subject to Applicable Nonqualified Option Agreement

Performance Milestone Option Agreement
Corresponding Bahr Option Agreement
75,000 shares of Common Stock
37,500 shares of Common Stock

The only material difference between the Time Vesting Option Agreement and the corresponding Bahr Option Agreement is the number of shares of Common Stock that is subject to each option agreement as set forth below:

Number of Shares of Common Stock
Subject to Applicable Nonqualified Option Agreement

Time Vesting Option Agreement
Corresponding Bahr Option Agreement
75,000 shares of Common Stock
37,500 shares of Common Stock




- 1 -








May 10, 2017

Richard L. Simons
6089 Club 15 Road, PO Box 201
Hector, NY 14841


Re:    Consulting Services Agreement

Dear Rick:

This letter agreement will confirm the terms and conditions of your engagement to provide consulting services to Hardinge Inc. (“ Company ”). The terms of the engagement are as follows:

1.     Engagement . The Company engages you, and you agree to be engaged by the Company, as an independent contractor to provide consulting services to the Company in connection with transitioning your former duties as President and Chief Executive Officer of the Company to your successor (collectively, “ Services ”). The Services will include, but not be limited to, introducing your successor to key constituencies of the Company, including, customers, vendors, managers and other strategic partners, and transferring the Company goodwill associated with these relationships to your successor. You will perform the Services in an efficient, trustworthy and professional manner. In performing the Services, you will conform to the highest standards of professional practice and performance.

2.     Manner of Providing Services . You will provide Services to the Company during normal business hours as and when requested by the Company’s President and Chief Executive Officer. You shall not be required to devote more than 80 hours per Month (as hereinafter defined) to the Services. To avoid inconvenience or conflict with respect to your other business or personal affairs, the Company will use reasonable efforts to allow you to provide Services using telephone, electronic mail or other means of communications. Notwithstanding the foregoing, if reasonably requested by the Company’s President and Chief Executive Officer, you will agree to travel, including international travel, to perform the Services.

3.     Independent Contractor . You will be an independent contractor to the Company. Except as otherwise specifically contemplated by the terms of your separation of employment from the Company, you will not be entitled to participate in any benefit plan or program for employees of the Company, including, without limitation, any plan or program for life, medical, dental, accident, or travel insurance, profit sharing, vacation, sick leave, retirement savings or retirement benefits. For all purposes, including, but not limited to, the Federal Insurance Contributions Act (FICA), the Social Security Act, the Federal Unemployment Tax Act (FUTA), income tax withholding and any and all federal, state and local laws, rules and regulations, you shall be treated as an independent contractor and not as an employee of the Company. You acknowledge and agree that you are responsible for the payment of all income taxes with respect to compensation the Company pays you for the Services.

4.     Consulting Fee . In consideration for the Services, the Company will pay you a consulting fee in the amount of $38,500 per Month (the “ Consulting Fee ”). The Consulting Fee will be paid to you in arrears, on or about the last day of each Month.

5.     Expenses . You will be entitled to reimbursement for reasonable and necessary out-of-pocket expenses you incur in furtherance of your performance of the Services provided that you submit to the Company, appropriate receipts, reports, and/or documentation with respect to such expenses. Reimbursement payments will be made within 30 days of receipt of the aforesaid receipts, reports and/or documentation.

6.     Term of Engagement . The engagement shall commence on May 11, 2017 and remain in effect for three consecutive Months, unless terminated earlier by either party for cause. For the purposes of this letter agreement, “Month” means a 30 day period, with the first Month commencing on May 11, 2017.

7.     Confidential Information . You acknowledge that in the course of your engagement as a consultant pursuant to this letter agreement, you may continue to have access to certain facts and information regarding the operations, finances and strategic initiatives of the Company and its affiliates. All such information is to be held by you in strict confidence, and will be subject to the applicable post-separation provisions of your Employment Agreement with the Company.

8.     Reports . Throughout the term of the engagement, you will furnish to the Company when and as requested, reports and records relating to Services. All such reports and records will be the sole property of the Company. Upon termination of the engagement for any reason, you will promptly deliver to the Company all documents and materials relating to the Company or the Services, without retaining any copy thereof.

9.     Separation from Service .  Under applicable Treasury Regulations, you are not deemed to have a “separation from service” for purposes of determining when deferred compensation can be paid to you, under your employment agreement and under the Hardinge Nonqualified Deferred Compensation Plan (the “SERP”), until the date when you and the Company no longer expect you to provide at least 30 hours per month of services to the Company as either an employee or an independent contractor.  Because you may provide more than 30 hours of services per month to the Company as an independent contractor during the 90 day term of this letter agreement, your “separation from service” with the Company for purposes of the deferred compensation payable to you under your employment agreement and the SERP will be your last day as an independent contractor under this letter agreement rather than your last day as an employee under your employment agreement.   Specifically, under your employment agreement your will receive (1) six months of Base Salary in a lump sum within 60 days of your termination of employment as stated in that agreement, and (2) all welfare benefits to be provided to you under the terms of the employment agreement will be provided as started in that agreement, but (3) the balance of your severance pay under Section 5.2.1 that agreement will begin payment on the 6-month anniversary of the day following the last day of this letter  agreement.  Similarly, your “Separation from Service” within the meaning of the SERP will be the 6-month anniversary of the day following the last day of this letter agreement.

10.     Miscellaneous . This letter agreement constitutes the entire agreement between you and the Company regarding your engagement to provide Services to the Company. This letter agreement may not be modified, except in a writing signed by you and the Company.

Please indicate your agreement with the foregoing by execution of the enclosed counterpart of this letter.

Very truly yours,

HARDINGE INC.



By _______________________________________
Mitchell I. Quain, Lead Independent Director



Agreed to as of this 10th day of May, 2017:


By_______________________________________
Richard L. Simons



EXHIBIT 31.1
 
HARDINGE INC.
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Charles P. Dougherty, certify that:
 
1.  I have reviewed this quarterly report on Form 10-Q of Hardinge Inc.;
 
2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.  The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)            Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)            Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)             Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)            Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.  The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)            All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)            Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date:
August 3, 2017
/s/ Charles P. Dougherty
 
 
Charles P. Dougherty
 
 
President and Chief Executive Officer
 
 
 




EXHIBIT 31.2
 
HARDINGE INC.
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Douglas J. Malone, certify that:
 
1.  I have reviewed this quarterly report on Form 10-Q of Hardinge Inc.;
 
2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.  The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)            Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)            Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)             Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)            Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.  The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)            All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)            Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date:
August 3, 2017
/s/ Douglas J. Malone
 
 
Douglas J. Malone
 
 
Senior Vice President and Chief Financial Officer
 
 
(Principal Financial Officer)




EXHIBIT 32
 
HARDINGE INC.
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of Hardinge Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles P. Dougherty, President and Chief Executive Officer of the Company and I, Douglas J. Malone, Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:
 
(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
/s/ Charles P. Dougherty
 
Charles P. Dougherty
 
President and Chief Executive Officer
 
August 3, 2017
 
 
 
 
 
/s/ Douglas J. Malone
 
Douglas J. Malone
 
Senior Vice President and Chief Financial Officer
 
(Principal Financial Officer)
 
August 3, 2017
 
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to Hardinge Inc. and will be retained by Hardinge Inc. and furnished to the Securities and Exchange Commission or its staff upon request.